CAS 36505-84-7 | 8-Azaspiro[4.5]decane-7,9-dione,8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]- | CAS Number 36505-84-7

Title	Journal
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone.	Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20140701
Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.	Toxicological sciences : an official journal of the Society of Toxicology 20140101
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery.	Journal of psychiatric research 20121201
Intravenous buspirone for the prevention of postoperative nausea and vomiting.	European journal of clinical pharmacology 20121101
The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.	Journal of neural transmission (Vienna, Austria : 1996) 20121101
LC-ESI-MS/MS analysis and pharmacokinetics of 6'-hydroxy justicidin A, a potential antitumor active component isolated from Justicia procumbens, in rats.	Journal of pharmaceutical and biomedical analysis 20121101
Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.	Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20121101
Performance in anxiety and spatial memory tests following bilateral vestibular loss in the rat and effects of anxiolytic and anxiogenic drugs.	Behavioural brain research 20121101
Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia.	Journal of clinical pharmacy and therapeutics 20121001
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.	Psychopharmacology 20121001
Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.	Biochemical pharmacology 20121001
The immediate and the delayed effects of buspirone on zebrafish (Danio rerio) in an open field test: a 3-D approach.	Behavioural brain research 20121001
Buspirone blocks the enhancing effect of the anxiogenic drug RS 79948-197 on consolidation of habit memory.	Behavioural brain research 20121001
Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.	Journal of ethnopharmacology 20120928
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.	Neurobiology of disease 20120901
Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.	Contemporary clinical trials 20120901
Treating anxiety by discontinuing antidepressants: a case series.	Medical hypotheses 20120901
Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model.	Brain research 20120827
Application of a sensitive and specific LC-MS/MS method for determination of chinensinaphthol methyl ether in rat plasma for a bioavailability study.	Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120815
Pharmacotherapy to control behavioral symptoms in children with autism.	Expert opinion on pharmacotherapy 20120801
Two weeks of buspirone protects against posthypoxic ventilatory pauses in the C57BL/6J mouse strain.	Respiratory physiology & neurobiology 20120731
Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers.	Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20120701
Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.	Journal of neurotrauma 20120701
Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.	Journal of neurotrauma 20120701
Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression.	Pharmacology, biochemistry, and behavior 20120701
Psychopharmacologic treatment of children and adolescents with anxiety disorders.	Child and adolescent psychiatric clinics of North America 20120701
A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds.	Bioanalysis 20120701
Buspirone: what is it all about?	Brain research 20120621
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors: part II.	Bioorganic & medicinal chemistry letters 20120615
Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.	Journal of medicinal chemistry 20120614
Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist.	The AAPS journal 20120601
Determinants of effective cooling during endovascular hypothermia.	Neurocritical care 20120601
The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats.	Croatian medical journal 20120601
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.	Journal of medicinal chemistry 20120524
Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.	Behavioural brain research 20120516
Functional and physiological effects of treadmill training induced by buspirone, carbidopa, and L-DOPA in clenbuterol-treated paraplegic mice.	Neurorehabilitation and neural repair 20120501
The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.	Psychopharmacology 20120501
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.	Acta psychiatrica Scandinavica 20120401
The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.	European journal of nuclear medicine and molecular imaging 20120401
The role of serotonin in the regulation of patience and impulsivity.	Molecular neurobiology 20120401
Visual social preferences of lone zebrafish in a novel environment: strain and anxiolytic effects.	Genes, brain, and behavior 20120401
An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD.	The Journal of clinical psychiatry 20120401
Asian consensus report on functional dyspepsia.	Journal of neurogastroenterology and motility 20120401
A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide.	Journal of affective disorders 20120301
Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.	European journal of medicinal chemistry 20120301
Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardee.	Basic & clinical pharmacology & toxicology 20120301
Use of buspirone and fluoxetine for breathing problems in Rett syndrome.	Pediatric neurology 20120301
Prescribing trends in veterans with posttraumatic stress disorder.	The Journal of clinical psychiatry 20120301
Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration.	Molecular psychiatry 20120201
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.	Journal of clinical psychopharmacology 20120201
Paroxetine-induced severe sleep bruxism successfully treated with buspirone.	Clinics (Sao Paulo, Brazil) 20120201
A novel G protein-coupled receptor of Schistosoma mansoni (SmGPR-3) is activated by dopamine and is widely expressed in the nervous system.	PLoS neglected tropical diseases 20120201
Quantitative analysis of atractylenolide I in rat plasma by LC-MS/MS method and its application to pharmacokinetic study.	Journal of pharmaceutical and biomedical analysis 20120125
Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene.	Human mutation 20120101
Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.	Parkinson's disease 20120101
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.	Journal of drug delivery 20120101
An efficient synthesis of aripiprazole, buspirone and NAN-190 by the reductive alkylation of amines procedure.	Archiv der Pharmazie 20120101
The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.	Parkinson's disease 20120101
Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey.	BMC public health 20120101
A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from generalized anxiety disorder with or without comorbidities.	International journal of yoga 20120101
Prediction of psilocybin response in healthy volunteers.	PloS one 20120101
Iontophoresis: a potential emergence of a transdermal drug delivery system.	Scientia pharmaceutica 20120101
Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide.	Harm reduction journal 20120101
Resource utilization and costs before and after total joint arthroplasty.	BMC health services research 20120101
The 5HT1a receptor agonist 8-Oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium.	PloS one 20120101
Housing conditions differentially affect physiological and behavioural stress responses of zebrafish, as well as the response to anxiolytics.	PloS one 20120101
A survey of patient preferences for a placebo orodispersible tablet.	Patient preference and adherence 20120101
Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use.	Neuropsychiatric disease and treatment 20120101
Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?	Advances in pharmacological sciences 20120101
Testing homeopathy in mouse emotional response models: pooled data analysis of two series of studies.	Evidence-based complementary and alternative medicine : eCAM 20120101
An overview of the evidence and mechanisms of herb-drug interactions.	Frontiers in pharmacology 20120101
Huntington's disease.	Handbook of clinical neurology 20120101
Measures of anxiety in zebrafish (Danio rerio): dissociation of black/white preference and novel tank test.	PloS one 20120101
Treatment-resistant Schizophrenia: Evidence-based Strategies.	Mens sana monographs 20120101
Treatment-resistant depression: therapeutic trends, challenges, and future directions.	Patient preference and adherence 20120101
Optimal treatment of social phobia: systematic review and meta-analysis.	Neuropsychiatric disease and treatment 20120101
Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.	International journal of nanomedicine 20120101
Understanding and prevention of 'therapy-' induced dyskinesias.	Parkinson's disease 20120101
Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease.	Parkinson's disease 20120101
The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.	PloS one 20120101
Quetiapine and Buspirone Both Elevate Cortical Levels of Noradrenaline and Dopamine In vivo, but Do Not have Synergistic Effects.	Frontiers in psychiatry 20120101
Interventions for treating anxiety after stroke.	The Cochrane database of systematic reviews 20111207
Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity.	Journal of psychopharmacology (Oxford, England) 20111201
Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.	Journal of neural transmission (Vienna, Austria : 1996) 20111201
Antidepressant-like properties of sarizotan in experimental Parkinsonism.	Psychopharmacology 20111201
Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified.	Journal of child and adolescent psychopharmacology 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).	PLoS computational biology 20111201
Pharmacotherapy of anxiety disorders: a critical review.	Dialogues in clinical neuroscience 20111201
Pharmacotherapy for anxiety disorders in children and adolescents.	Dialogues in clinical neuroscience 20111201
Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.	Rapid communications in mass spectrometry : RCM 20111115
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?	Depression and anxiety 20111101
Pharmacological treatment of generalized anxiety disorder.	Expert opinion on pharmacotherapy 20111101
Buspirone before prenatal stress protects against adverse effects of stress on emotional and inflammatory pain-related behaviors in infant rats: age and sex differences.	Brain research 20111024
A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.	Journal of clinical psychopharmacology 20111001
Patterns of avoidance behaviours in the light/dark preference test in young juvenile zebrafish: a pharmacological study.	Behavioural brain research 20110912
5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.	Neuropharmacology 20110901
Attenuation of apomorphine-induced sensitization by buspirone.	Pharmacology, biochemistry, and behavior 20110901
Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol.	Pharmacology, biochemistry, and behavior 20110901
Physiologically based pharmacokinetic modeling of intestinal first-pass metabolism of CYP3A substrates with high intestinal extraction.	Drug metabolism and disposition: the biological fate of chemicals 20110901
Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.	Gut and liver 20110901
Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.	Psychiatry investigation 20110901
Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.	Current neuropharmacology 20110901
Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.	Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20110801
Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma.	Journal of pharmaceutical and biomedical analysis 20110715
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.	Journal of medicinal chemistry 20110714
Phasic and sustained fear are pharmacologically dissociable in rats.	Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110701
Species independence in brain tissue binding using brain homogenates.	Drug metabolism and disposition: the biological fate of chemicals 20110701
The effect of component of microemulsions on transdermal delivery of buspirone hydrochloride.	Journal of pharmaceutical sciences 20110601
Emerging drugs for functional dyspepsia.	Expert opinion on emerging drugs 20110601
[Serotonin receptor 1A-modulated dephosphorylation of glycine receptor α3: a new molecular mechanism of breathing control for compensation of opioid-induced respiratory depression without loss of analgesia].	Schmerz (Berlin, Germany) 20110601
Drug therapies for tardive dyskinesia: Part 1.	Journal of psychosocial nursing and mental health services 20110601
Adverse effects of oral nonstimulant psychotropic medications in young children reported to a regional poison center.	Clinical toxicology (Philadelphia, Pa.) 20110601
Covariation of EEG synchronization and emotional state as modified by anxiolytics.	Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20110601
Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.	Journal of medicinal chemistry 20110512
Simultaneous quantification of loureirin A and loureirin B in rat urine, feces, and bile by HPLC-MS/MS method and its application to excretion study.	Analytical and bioanalytical chemistry 20110501
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms.	Recent patents on CNS drug discovery 20110501
Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice.	Prescrire international 20110501
Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats.	Behavioural brain research 20110415
Development and evaluation of a multiple-plate fraction collector for sample processing: application to radioprofiling in drug metabolism studies.	Journal of pharmaceutical and biomedical analysis 20110405
Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress.	Investigative ophthalmology & visual science 20110404
Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys.	Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110401
The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.	The journal of sexual medicine 20110401
Pharmacological analysis of zebrafish (Danio rerio) scototaxis.	Progress in neuro-psychopharmacology & biological psychiatry 20110330
Vogel conflict test: sex differences and pharmacological validation of the model.	Behavioural brain research 20110317
Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.	Journal of endocrinological investigation 20110301
Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications.	European journal of nuclear medicine and molecular imaging 20110301
Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.	Psychiatry investigation 20110301
Acute tryptophan depletion attenuates conscious appraisal of social emotional signals in healthy female volunteers.	Psychopharmacology 20110201
Maternal buspirone protects against the adverse effects of in utero stress on emotional and pain-related behaviors in offspring.	Physiology & behavior 20110201
Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to α1-adrenergic receptors among arylpiperazine derivatives of phenytoin.	Bioorganic & medicinal chemistry 20110201
Application of a fluorescence-based continuous-flow bioassay to screen for diversity of cytochrome P450 BM3 mutant libraries.	Journal of biomolecular screening 20110201
Breast enlargement associated with low dose olanzapine.	Indian journal of pharmacology 20110201
[Effects of chronic buspirone treatment on female mice exposed to the long-lasting psychoemotional influence].	Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20110201
The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats.	Addiction biology 20110101
Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box.	Behavioural brain research 20110101
Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.	The journal of sexual medicine 20110101
SSR181507, a dopamine D₂ receptor and 5-HT(₁A) receptor ligand: evidence for mixed anxiolytic- and antidepressant-like activities.	Pharmacology, biochemistry, and behavior 20110101
Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior.	Journal of neurochemistry 20110101
Activation of the central serotonergic system in response to delayed but not omitted rewards.	The European journal of neuroscience 20110101
5-HT receptors mediate lineage-dependent effects of serotonin on adult neurogenesis in Procambarus clarkii.	Neural development 20110101
Influence of enriched environment on viral encephalitis outcomes: behavioral and neuropathological changes in albino Swiss mice.	PloS one 20110101
Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.	Trials 20110101
Megafaunal community structure of Andaman seamounts including the Back-arc Basin--a quantitative exploration from the Indian Ocean.	PloS one 20110101
Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?	Annals of general psychiatry 20110101
Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.	BMC complementary and alternative medicine 20110101
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model.	International journal of nanomedicine 20110101
Pharmacological treatment of cannabis dependence.	Current pharmaceutical design 20110101
A meta-analysis of studies of treatments for feline urine spraying.	PloS one 20110101
Targeting nicotine addiction: the possibility of a therapeutic vaccine.	Drug design, development and therapy 20110101
Postural control in bipolar disorder: increased sway area and decreased dynamical complexity.	PloS one 20110101
Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.	Reviews in the neurosciences 20110101
Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.	Molecular brain 20110101
Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective.	Pathology research international 20110101
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.	Journal of pharmacy & bioallied sciences 20110101
Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome.	Frontiers in pharmacology 20110101
Duloxetine-induced nocturnal bruxism resolved by buspirone: case report.	Clinical neuropharmacology 20110101
Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting - a retrospective case series.	Journal of pharmacology & pharmacotherapeutics 20110101
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.	Frontiers in systems neuroscience 20110101
Antinociceptive activity of the chloroform fraction of Dioclea virgata (Rich.) Amshoff (Fabaceae) in mice.	Journal of biomedicine & biotechnology 20110101
Expression and function of serotonin 2A and 2B receptors in the mammalian respiratory network.	PloS one 20110101
Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient mice.	PloS one 20110101
Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.	Therapeutics and clinical risk management 20110101
Histaminergic mechanisms for modulation of memory systems.	Neural plasticity 20110101
Identification of novel functional inhibitors of acid sphingomyelinase.	PloS one 20110101
Gelsemium sempervirens and Animal Behavioral Models.	Frontiers in neurology 20110101
Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research.	The Journal of neuropsychiatry and clinical neurosciences 20110101
Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.	The primary care companion for CNS disorders 20110101
Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.	Pharmacological reports : PR 20110101
Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial.	Critical care (London, England) 20110101
Extended course of repetitive trans-cranial magnetic stimulation therapy and a complicated case of obsessive-compulsive disorder.	Indian journal of psychological medicine 20110101
Generalised anxiety disorder.	BMJ clinical evidence 20110101
Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.	Journal of biomedical science 20110101
Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence.	Advances in pharmacological sciences 20110101
An fMRI study on the role of serotonin in reactive aggression.	PloS one 20110101
Exploration of sex differences in Rhes effects in dopamine mediated behaviors.	Neuropsychiatric disease and treatment 20110101
Subchronic treatment with fluoxetine attenuates the proerectile effect of Aspidosperma ulei Markgr (Apocyanaceae).	Indian journal of pharmacology 20110101
Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study.	BMC psychiatry 20110101
Therapeutic hypothermia in stroke and traumatic brain injury.	Frontiers in neurology 20110101
Augmentation effect of repetitive transcranial magnetic stimulation over the supplementary motor cortex in treatment refractory patients with obsessive compulsive disorder.	Indian journal of psychiatry 20110101
Effect of pomegranate pretreatment on the oral bioavailability of buspirone in male albino rabbits.	Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101
5-HT(1A) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats.	Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101
Hydroxyzine for generalised anxiety disorder.	The Cochrane database of systematic reviews 20101208
Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.	Journal of liposome research 20101201
Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.	Child psychiatry and human development 20101201
Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome.	Journal of pain and symptom management 20101201
Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray.	Experimental neurology 20101201
A predictive ligand-based Bayesian model for human drug-induced liver injury.	Drug metabolism and disposition: the biological fate of chemicals 20101201
Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N-phenylbenzo[b]thiophene-3-carboxamide.	European journal of medicinal chemistry 20101201
A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.	Journal of clinical psychopharmacology 20101201
An interesting case of serotonin syndrome precipitated by escitalopram.	Indian journal of pharmacology 20101201
Pregnancy in woman with spinal cord stimulator for complex regional pain syndrome: a case report and review of the literature.	The Korean journal of pain 20101201
[Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies].	Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20101201
Brain serotonergic circuitries.	Dialogues in clinical neuroscience 20101201
The serotonin syndrome-the need for physician's awareness.	International journal of emergency medicine 20101201
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.	Healthcare informatics research 20101201
Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys.	Drug metabolism and disposition: the biological fate of chemicals 20101101
Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.	Current drug metabolism 20101101
QEEG Measures in Huntington's Disease: A Pilot Study.	PLoS currents 20101025
Evaluation of antianxiety and sedative effects of essential oil of Ducrosia anethifolia in mice.	Clinics (Sao Paulo, Brazil) 20101001
Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.	Cancer prevention research (Philadelphia, Pa.) 20100901
Treatment of Irritability in Huntington's Disease.	Current treatment options in neurology 20100901
Conversion phenomenon during the induction period of general anesthesia -A case report-.	Korean journal of anesthesiology 20100901
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.	Current neuropharmacology 20100901
Graft-induced dyskinesias in Parkinson's disease: what is it all about?	Cell stem cell 20100806
Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus.	The international journal of neuropsychopharmacology 20100801
5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia.	Psychopharmacology 20100801
Identification and quantification of 30 antipsychotics in blood using LC-MS/MS.	Journal of mass spectrometry : JMS 20100801
Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study.	Brain research 20100723
Antidepressant-like effect of Salvia sclarea is explained by modulation of dopamine activities in rats.	Journal of ethnopharmacology 20100706
Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice.	Psychopharmacology 20100701
The pharmacologic treatment of anxiety disorders: a review of progress.	The Journal of clinical psychiatry 20100701
Effect of acute and chronic buspirone administration on communicativeness of mice with experience of defeats in social conflicts.	Bulletin of experimental biology and medicine 20100701
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.	Science translational medicine 20100630
Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.	Fundamental & clinical pharmacology 20100601
Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation.	Drug metabolism and disposition: the biological fate of chemicals 20100601
Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box-Behnken statistical design.	AAPS PharmSciTech 20100601
Drug treatment of obsessive-compulsive disorder.	Dialogues in clinical neuroscience 20100601
Body dysmorphic disorder.	Dialogues in clinical neuroscience 20100601
Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment.	Psychoneuroendocrinology 20100501
Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice.	Journal of neuroscience methods 20100430
Buspirone-induced changes in the serotonergic and non-serotonergic cells in the dorsal raphe nucleus of rats.	Neuroscience letters 20100405
Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.	Journal of psychopharmacology (Oxford, England) 20100401
Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder.	Psychiatry and clinical neurosciences 20100401
Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).	Bioorganic & medicinal chemistry letters 20100401
Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy.	Biotechnology journal 20100401
Buspirone attenuates tolerance to analgesic effect of morphine in mice with skin cancer.	Pakistan journal of pharmaceutical sciences 20100401
Therapeutic hypothermia for acute ischemic stroke.	Expert review of cardiovascular therapy 20100401
[Effects of prenatal influences of buspirone and stress on indices of inflammatory pain response and depressive behaviour in adult rats].	Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20100401
Effects of serotonin agonists and doxapram on respiratory depression and hypoxemia in etorphine-immobilized impala (Aepyceros melampus).	Journal of wildlife diseases 20100401
The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation.	Behavioural brain research 20100317
Oxidative stress in rat hippocampus caused by pilocarpine-induced seizures is reversed by buspirone.	Brain research bulletin 20100316
Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.	Biological psychiatry 20100315
Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies.	International journal of pharmaceutics 20100315
5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.	European archives of psychiatry and clinical neuroscience 20100301
Effects of amantadine on circulating neurotransmitters in healthy subjects.	Journal of neural transmission (Vienna, Austria : 1996) 20100301
Past, present and future therapeutics for cerebellar ataxias.	Current neuropharmacology 20100301
Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds.	FEBS letters 20100219
Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.	Journal of medicinal chemistry 20100211
Effect of serotonergic system on AVP secretion induced by physical exercise.	Neuropeptides 20100201
Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.	Headache 20100201
The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics.	Pharmacology, biochemistry, and behavior 20100201
Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates.	BMC neuroscience 20100101
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.	The Journal of neuropsychiatry and clinical neurosciences 20100101
Identification of molecular targets associated with ethanol toxicity and implications in drug development.	Current pharmaceutical design 20100101
Mouse models of apnea: strain differences in apnea expression and its pharmacologic and genetic modification.	Advances in experimental medicine and biology 20100101
Aggression and anxiety: social context and neurobiological links.	Frontiers in behavioral neuroscience 20100101
Impact of resilience enhancing programs on youth surviving the Beslan school siege.	Child and adolescent psychiatry and mental health 20100101
Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.	Arzneimittel-Forschung 20100101
Medications acting on the serotonergic system for the treatment of alcohol dependent patients.	Current pharmaceutical design 20100101
Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats.	Pharmacological reports : PR 20100101
Current trends in drug treatment of obsessive-compulsive disorder.	Neuropsychiatric disease and treatment 20100101
Application of a naturalistic psychogenic stressor in periadolescent mice: effect on serum corticosterone levels differs by strain but not sex.	BMC research notes 20100101
Line bisection performance in patients with generalized anxiety disorder and treatment-resistant depression.	International journal of medical sciences 20100101
Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.	Tobacco induced diseases 20100101
Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.	Frontiers in neuroscience 20100101
Adult zebrafish as a model organism for behavioural genetics.	BMC neuroscience 20100101
Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.	Primary care companion to the Journal of clinical psychiatry 20100101
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.	BMC medicine 20100101
Principal component analysis of HPLC retention data and molecular modeling structural parameters of cardiovascular system drugs in view of their pharmacological activity.	International journal of molecular sciences 20100101
The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients.	BMC neurology 20100101
Getting the balance right: Established and emerging therapies for major depressive disorders.	Neuropsychiatric disease and treatment 20100101
Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.	Nutrition journal 20100101
Tricyclic antidepressants and headaches: systematic review and meta-analysis.	BMJ (Clinical research ed.) 20100101
What alternatives to first-line therapy for depression are effective?	The Journal of clinical psychiatry 20100101
Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?	BMC medicine 20100101
A new strategy for antidepressant prescription.	Frontiers in neuroscience 20100101
Acute administration of clozapine and risperidone altered dopamine metabolism more in rat caudate than in nucleus accumbens: a dose-response relationship.	Scientia pharmaceutica 20100101
Effect of itraconazole on the pharmacokinetics of diclofenac in beagle dogs.	Scientia pharmaceutica 20100101
Fourth revolution in psychiatry - Addressing comorbidity with chronic physical disorders.	Indian journal of psychiatry 20100101
The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis.	Frontiers in neurology 20100101
Integrated management strategies for chronic obstructive pulmonary disease.	Journal of multidisciplinary healthcare 20100101
A Simple RP-HPLC Method for Quantitation of Itopride HCl in Tablet Dosage Form.	Journal of young pharmacists : JYP 20100101
The geriatric population and psychiatric medication.	Mens sana monographs 20100101
Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome.	Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Antidepressant-associated sexual dysfunction: impact, effects, and treatment.	Drug, healthcare and patient safety 20100101
Patent protection strategies.	Journal of pharmacy & bioallied sciences 20100101
Indian Psychiatry and Indian Journal of Psychiatry - A journey.	Indian journal of psychiatry 20100101
An overview of Indian research in anxiety disorders.	Indian journal of psychiatry 20100101
Psychological interventions in the management of common skin conditions.	Psychology research and behavior management 20100101
Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors.	Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101
Effect of pomegranate juice pre-treatment on the transport of carbamazepine across rat intestine.	Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101
A sensitive LC-MS/MS method to quantify loureirin B in rat plasma with application to preclinical pharmacokinetic studies.	Journal of pharmaceutical and biomedical analysis 20091205
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.	Bioorganic & medicinal chemistry letters 20091201
PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety.	Pharmacology, biochemistry, and behavior 20091101
Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety.	Pharmacology, biochemistry, and behavior 20091101
Defeating normal thermoregulatory defenses: induction of therapeutic hypothermia.	Stroke 20091101
A placebo-controlled trial of buspirone for the treatment of marijuana dependence.	Drug and alcohol dependence 20091101
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.	Psychiatric services (Washington, D.C.) 20091101
The effects of buspirone and diazepam on aversive context- and social isolation-induced ultrasonic vocalisation.	Physiology & behavior 20091019
Physical binding pocket induction for affinity prediction.	Journal of medicinal chemistry 20091008
Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.	The Journal of pharmacology and experimental therapeutics 20091001
Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.	Psychopharmacology 20091001
Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.	Biochemical pharmacology 20090915
Serotonin targets inhibitory synapses to induce modulation of network functions.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20090912
Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.	Rapid communications in mass spectrometry : RCM 20090901
Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.	The Journal of pharmacy and pharmacology 20090901
Development of high performance liquid chromatography method for buspirone in rabbit serum: Application to pharmacokinetic study.	Analytica chimica acta 20090811
Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.	European journal of nuclear medicine and molecular imaging 20090801
Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.	Psychopharmacology 20090801
STAR*D: revising conventional wisdom.	CNS drugs 20090801
Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.	Human psychopharmacology 20090801
Carboxy group derivatization for enhanced electron-transfer dissociation mass spectrometric analysis of phosphopeptides.	Proteomics 20090801
Classification of 5-HT(1A) receptor ligands on the basis of their binding affinities by using PSO-Adaboost-SVM.	International journal of molecular sciences 20090801
The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.	Psychopharmacology 20090701
Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.	Psychopharmacology 20090701
Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.	Psychopharmacology 20090701
Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers.	Anesthesiology 20090701
Thermoregulatory defense mechanisms.	Critical care medicine 20090701
Gabapentin-induced delirium and dependence.	Journal of psychiatric practice 20090701
Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features.	International journal of environmental research and public health 20090701
Inhibitory effect of fentanyl on phenylephrine-induced contraction of the rat aorta.	Yonsei medical journal 20090630
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.	Toxicology and applied pharmacology 20090615
The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica).	European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090601
Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model.	Planta medica 20090601
Proposal of buspirone collision-induced dissociation rearrangement by exact mass measurements.	Rapid communications in mass spectrometry : RCM 20090601
Spectroscopic study of the reaction mechanism of buspirone interaction with iodine and tetracyanoethylene reagents and its applications.	Drug testing and analysis 20090601
5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.	Journal of clinical medicine research 20090601
Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.	Journal of neuroscience methods 20090530
Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.	Journal of medicinal chemistry 20090528
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.	The international journal of neuropsychopharmacology 20090501
Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.	Pharmacology, biochemistry, and behavior 20090501
Ice-cold saline for the induction of mild hypothermia in patients with acute ischemic stroke: a pilot study.	Stroke 20090501
Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.	The Journal of pharmacy and pharmacology 20090501
Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.	Psychopharmacology 20090401
Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.	European journal of pharmacology 20090401
Algorithm for thorough background subtraction of high-resolution LC/MS data: application to obtain clean product ion spectra from nonselective collision-induced dissociation experiments.	Analytical chemistry 20090401
[Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].	L'Encephale 20090401
The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.	Journal of clinical gastroenterology 20090301
Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats.	Alcoholism, clinical and experimental research 20090301
Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers.	Planta medica 20090301
Synthesis and pharmacological evaluation of new arylpiperazines N-[4-[4-(aryl) piperazine-1-yl]-phenyl]-amine derivatives: putative role of 5-HT1A receptors.	Bioorganic & medicinal chemistry 20090301
Involvement of the subthalamic nucleus in engagement with behaviourally relevant stimuli.	The European journal of neuroscience 20090301
Psychoactive medication and traffic safety.	International journal of environmental research and public health 20090301
Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists.	Bioorganic & medicinal chemistry letters 20090215
Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers.	Journal of pharmaceutical sciences 20090201
The influence of an ethylene spacer on the 5-HT(1A) and 5-HT(2A) receptor affinity of arylpiperazine derivatives of amides with N-acylated amino acids and 3-differently substituted pyrrolidine-2,5-diones.	European journal of medicinal chemistry 20090201
Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study.	Neuropharmacology 20090201
Prevalence of ergot derivatives in natural ryegrass pastures: detection and pathogenicity in the horse.	Theriogenology 20090201
Antinociceptive activity of Tilia americana var. mexicana inflorescences and quercetin in the formalin test and in an arthritic pain model in rats.	Neuropharmacology 20090201
Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy.	Indian journal of pharmacology 20090201
Synthesis and serotonin receptor activity of the arylpiperazine alkyl/propoxy derivatives of new azatricycloundecanes.	European journal of medicinal chemistry 20090101
Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient.	Spinal cord 20090101
5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography.	Alcohol and alcoholism (Oxford, Oxfordshire) 20090101
Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats.	Neurochemistry international 20090101
[Alternative agents used in ADHD].	Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20090101
Augmentation strategies for treatment-resistant depression.	Current opinion in psychiatry 20090101
Worsening of bruxism with atomoxetine: a case report.	The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101
Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia.	Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20090101
Refractory generalized anxiety disorder.	The Journal of clinical psychiatry 20090101
Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats.	Neuropharmacology 20090101
Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.	Neuropharmacology 20090101
Obsessive-compulsive disorder and related disorders: a comprehensive survey.	Annals of general psychiatry 20090101
Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue.	BMC gastroenterology 20090101
Effect of buspirone on thermal sensory and pain thresholds in human volunteers.	BMC clinical pharmacology 20090101
Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly?	BMC geriatrics 20090101
Field torso-warming modalities: a comparative study using a human model.	Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 20090101
[STAR* D study: searching strategies regarding lack of response to an SSRI].	Vertex (Buenos Aires, Argentina) 20090101
Pharmacotherapy for cannabis dependence: how close are we?	CNS drugs 20090101
Duloxetine for the treatment of generalized anxiety disorder: a review.	Neuropsychiatric disease and treatment 20090101
Reduction of the number of new cells reaching olfactory bulbs impairs olfactory perception in the adult opossum.	Acta neurobiologiae experimentalis 20090101
Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder.	BMC geriatrics 20090101
Interactions between herbal medicines and prescribed drugs: an updated systematic review.	Drugs 20090101
Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression.	Psychotherapy and psychosomatics 20090101
Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report.	Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 20090101
More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.	Indian journal of psychiatry 20090101
A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.	Clinical pharmacokinetics 20090101
A systematic review of augmentation strategies for patients with major depressive disorder.	Psychopharmacology bulletin 20090101
Drugs associated with more suicidal ideations are also associated with more suicide attempts.	PloS one 20090101
Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation.	PloS one 20090101
Emotional reactivity and cognitive performance in aversively motivated tasks: a comparison between four rat strains.	Behavioral and brain functions : BBF 20090101
Depression with panic episodes and coronary vasospasm.	Cardiovascular psychiatry and neurology 20090101
Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation.	Oxidative medicine and cellular longevity 20090101
Computerized assessment of social approach behavior in mouse.	Frontiers in behavioral neuroscience 20090101
Duloxetine in the treatment of generalized anxiety disorder.	International journal of general medicine 20090101
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy.	Core evidence 20090101
Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder.	International journal of women's health 20090101
Behavioral and psychological symptoms of dementia and their management.	Indian journal of psychiatry 20090101
Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?	Behavioural brain research 20081216
Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response.	Progress in neuro-psychopharmacology & biological psychiatry 20081212
Influence of buspirone on gastric sensorimotor function in man.	Alimentary pharmacology & therapeutics 20081201
Prokinetics and fundic relaxants in upper functional GI disorders.	Current opinion in pharmacology 20081201
Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system.	Planta medica 20081201
Towards achieving remission in the treatment of depression.	Dialogues in clinical neuroscience 20081201
Treatment strategies to improve and sustain remission in major depressive disorder.	Dialogues in clinical neuroscience 20081201
Incomplete remission in depression: role of psychiatric and somatic comorbidity.	Dialogues in clinical neuroscience 20081201
Diffusion tensor imaging of frontal lobe in autism spectrum disorder.	Cerebral cortex (New York, N.Y. : 1991) 20081101
Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release.	European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081101
Resistive polymer versus forced-air warming: comparable heat transfer and core rewarming rates in volunteers.	Anesthesia and analgesia 20081101
The molecular interactions of buspirone analogues with the serotonin transporter.	Bioorganic & medicinal chemistry 20081015
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.	Journal of medicinal chemistry 20081009
Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.	Advances in therapy 20081001
Dose-dependent response of central dopaminergic systems to buspirone in mice.	Indian journal of experimental biology 20081001
The role of duloxetine in the treatment of anxiety disorders.	Neuropsychiatric disease and treatment 20081001
Augmentation treatment in major depressive disorder: focus on aripiprazole.	Neuropsychiatric disease and treatment 20081001
Pharmacodynamic interaction of the sedative effects of Ternstroemia pringlei (Rose) Standl. with six central nervous system depressant drugs in mice.	Journal of ethnopharmacology 20080902
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.	Chemical research in toxicology 20080901
Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.	Current neuropharmacology 20080901
The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.	Journal of the neurological sciences 20080815
Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.	Journal of medicinal chemistry 20080814
Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains.	Journal of applied physiology (Bethesda, Md. : 1985) 20080801
Psychiatric disorders and traumatic brain injury.	Neuropsychiatric disease and treatment 20080801
Fluoxetine overdose-induced seizure.	The western journal of emergency medicine 20080801
Post-sigh breathing behavior and spontaneous pauses in the C57BL/6J (B6) mouse.	Respiratory physiology & neurobiology 20080731
Buspirone induced acute and chronic changes of neural activation in the periaqueductal gray of rats.	Neuroscience 20080731
Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists.	Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080701
Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model.	Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20080601
Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions.	European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080601
In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone.	Toxicological sciences : an official journal of the Society of Toxicology 20080601
Apneusis responding to buspirone in multiple sclerosis.	Multiple sclerosis (Houndmills, Basingstoke, England) 20080601
Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.	The AAPS journal 20080601
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.	Clinical interventions in aging 20080601
Validating an Ataxia Functional Composite Scale in spinocerebellar ataxia.	Journal of the neurological sciences 20080515
Buspirone and serotonin in spinocerebellar ataxia.	Journal of the neurological sciences 20080515
Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition.	Behavioural pharmacology 20080501
How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.	Journal of psychiatric practice 20080501
Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.	Die Pharmazie 20080501
Psychiatric issues in renal failure and dialysis.	Indian journal of nephrology 20080401
Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.	Brain research bulletin 20080328
Location and orientation of serotonin receptor 1a agonists in model and complex lipid membranes.	The Journal of biological chemistry 20080321
Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.	European journal of nuclear medicine and molecular imaging 20080301
Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models.	Pharmacology, biochemistry, and behavior 20080301
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.	The American journal of psychiatry 20080301
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?	European journal of nuclear medicine and molecular imaging 20080301
Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.	Body image 20080301
Quantitation of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS-MS.	Journal of analytical toxicology 20080301
Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.	Expert review of neurotherapeutics 20080301
End of life care in chronic obstructive pulmonary disease: in search of a good death.	International journal of chronic obstructive pulmonary disease 20080301
Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.	European journal of pharmacology 20080226
Pharmacological management of panic disorder.	Neuropsychiatric disease and treatment 20080201
Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs.	Pharmacology, biochemistry, and behavior 20080101
The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.	Pharmacology, biochemistry, and behavior 20080101
Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.	Pharmacology, biochemistry, and behavior 20080101
Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.	Basic & clinical pharmacology & toxicology 20080101
Buspirone for autistic disorder in a woman with an intellectual disability.	The Annals of pharmacotherapy 20080101
Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.	Journal of psychiatric practice 20080101
Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.	Malaria journal 20080101
Effects of midazolam and buspirone on in vivo concentration of amino acids and monoamine metabolites in the rat hippocampus.	Pharmacological reports : PR 20080101
Failed therapy and directions for the future in dyspepsia.	Digestive diseases (Basel, Switzerland) 20080101
Context and strain-dependent behavioral response to stress.	Behavioral and brain functions : BBF 20080101
Clinical drugs that interact with St. John's wort and implication in drug development.	Current pharmaceutical design 20080101
Effect of buspirone on the behavioral regulation of rats in low versus high anxiety conditions.	Arzneimittel-Forschung 20080101
Predatory stress as an experimental strategy to measure fear and anxiety-related behaviors in non-human primates.	Reviews in the neurosciences 20080101
Acoustic startle reflex in rhesus monkeys: a review.	Reviews in the neurosciences 20080101
Brain serotonin and dopamine modulators, perceptual responses and endurance performance during exercise in the heat following creatine supplementation.	Journal of the International Society of Sports Nutrition 20080101
Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.	PloS one 20080101
Imaging the neural circuitry and chemical control of aggressive motivation.	BMC neuroscience 20080101
Marijuana neurobiology and treatment.	Substance abuse 20080101
Rapid and sensitive characterization of the metabolite formation enzyme kinetics of radiolabeled drugs using stop-flow liquid radiochromatography.	Drug metabolism letters 20080101
Panic disorder.	BMJ clinical evidence 20080101
Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis.	Current drug metabolism 20071201
Management of the behavioral and psychological symptoms of dementia.	Clinical interventions in aging 20071201
Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors.	Acta biologica Hungarica 20071201
Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important?	Current neuropharmacology 20071201
[Pathologic worry].	MMW Fortschritte der Medizin 20071115
Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man.	Pharmaceutical research 20071101
Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor.	Journal of psychopharmacology (Oxford, England) 20071101
Behavioral response to emotional stress in rabbits: role of serotonin and serotonin2A receptors.	Behavioural pharmacology 20071101
Behavioural and pharmacological specificity of the effects of drugs on punished schedule-induced polydipsia.	Behavioural pharmacology 20071101
[Pharmacological therapy for therapy-resistant depression. New developments].	Der Nervenarzt 20071101
An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.	Journal of psychopharmacology (Oxford, England) 20071101
[Generalized anxiety disorder (GAD)--diagnosis and therapy].	Medizinische Monatsschrift fur Pharmazeuten 20071101
Response surface analysis of solution-mediated polymorphic transformation of buspirone hydrochloride.	Journal of pharmaceutical and biomedical analysis 20071018
Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats.	Psychopharmacology 20071001
Dose related effects of buspirone on serum electrolyte balance, plasma osmolality and systolic blood pressure (SBP) in rats.	Pakistan journal of pharmaceutical sciences 20071001
Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans.	Biopharmaceutics & drug disposition 20071001
alpha1-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats.	Naunyn-Schmiedeberg's archives of pharmacology 20071001
Augmentation strategies for treatment-resistant depression: a literature review.	Journal of clinical pharmacy and therapeutics 20071001
The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.	European archives of psychiatry and clinical neuroscience 20071001
Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.	Canadian journal of psychiatry. Revue canadienne de psychiatrie 20071001
Pharmacological causes of hyperprolactinemia.	Therapeutics and clinical risk management 20071001
[Resistant depression].	Revue medicale suisse 20070919
Treatment of spinocerebellar ataxia with buspirone.	Journal of the neurological sciences 20070915
Survey of management of acquired nystagmus in the United Kingdom.	Eye (London, England) 20070901
Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.	Alcoholism, clinical and experimental research 20070901
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.	Schizophrenia research 20070901
Neurotoxic syndrome developed after taking sertraline and risperidone.	Journal of clinical neurology (Seoul, Korea) 20070901
6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats.	Drug metabolism and disposition: the biological fate of chemicals 20070801
Hormonal response to buspirone is not impaired in major depression.	Human psychopharmacology 20070801
Glutamate and anxiety disorders.	Current psychiatry reports 20070801
An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.	Neuropsychiatric disease and treatment 20070801
Simultaneous determination of metabolic stability and identification of buspirone metabolites using multiple column fast liquid chromatography time-of-flight mass spectrometry.	Journal of chromatography. A 20070713
Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1.	Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070701
Solubility analysis of buspirone hydrochloride polymorphs: measurements and prediction.	International journal of pharmaceutics 20070629
Mass spectrometric investigation of buspirone drug in comparison with thermal analyses and MO-calculations.	Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070601
Unintentional onset of anorexia nervosa.	Eating and weight disorders : EWD 20070601
Frontal-subcortical circuitry and behavior.	Dialogues in clinical neuroscience 20070601
Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.	Progress in neuro-psychopharmacology & biological psychiatry 20070509
[Augmentation strategies for therapy resistant depression - a review].	Psychiatrische Praxis 20070501
Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.	Psychoneuroendocrinology 20070501
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.	The American journal of psychiatry 20070501
Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.	Pharmacology, biochemistry, and behavior 20070501
Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic?	Journal of psychiatric practice 20070501
Effects of buspirone on the immediate positive and delayed negative properties of intravenous cocaine as measured in the conditioned place preference test.	Pharmacology, biochemistry, and behavior 20070501
Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole blood.	Journal of analytical toxicology 20070501
Polycystic ovary syndrome and hyperprolactinemia are distinct entities.	Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070501
Premenstrual syndrome.	BMJ clinical evidence 20070501
Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model.	Behavioural brain research 20070416
Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.	Journal of ethnopharmacology 20070404
Treatment of generalized anxiety disorder.	Neuropsychiatric disease and treatment 20070401
Role of pregabalin in the treatment of generalized anxiety disorder.	Neuropsychiatric disease and treatment 20070401

LC-ESI-MS/MS analysis and pharmacokinetics of 6'-hydroxy justicidin A, a potential antitumor active component isolated from Justicia procumbens, in rats.

Journal of pharmaceutical and biomedical analysis 20121101

Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20121101

Performance in anxiety and spatial memory tests following bilateral vestibular loss in the rat and effects of anxiolytic and anxiogenic drugs.

Behavioural brain research 20121101

Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia.

Journal of clinical pharmacy and therapeutics 20121001

The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Psychopharmacology 20121001

Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.

Biochemical pharmacology 20121001

The immediate and the delayed effects of buspirone on zebrafish (Danio rerio) in an open field test: a 3-D approach.

Behavioural brain research 20121001

Buspirone blocks the enhancing effect of the anxiogenic drug RS 79948-197 on consolidation of habit memory.

Behavioural brain research 20121001

Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.

Journal of ethnopharmacology 20120928

Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.

Neurobiology of disease 20120901

Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.

Contemporary clinical trials 20120901

Treating anxiety by discontinuing antidepressants: a case series.

Medical hypotheses 20120901

Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model.

Brain research 20120827

Application of a sensitive and specific LC-MS/MS method for determination of chinensinaphthol methyl ether in rat plasma for a bioavailability study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120815

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert opinion on pharmacotherapy 20120801

Two weeks of buspirone protects against posthypoxic ventilatory pauses in the C57BL/6J mouse strain.

Respiratory physiology & neurobiology 20120731

Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20120701

Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.

Journal of neurotrauma 20120701

Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.

Journal of neurotrauma 20120701

Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression.

Pharmacology, biochemistry, and behavior 20120701

Psychopharmacologic treatment of children and adolescents with anxiety disorders.

Child and adolescent psychiatric clinics of North America 20120701

A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds.

Bioanalysis 20120701

Buspirone: what is it all about?

Brain research 20120621

Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors: part II.

Bioorganic & medicinal chemistry letters 20120615

Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.

Journal of medicinal chemistry 20120614

Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist.

The AAPS journal 20120601

Determinants of effective cooling during endovascular hypothermia.

Neurocritical care 20120601

The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats.

Croatian medical journal 20120601

Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.

Journal of medicinal chemistry 20120524

Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.

Behavioural brain research 20120516

Functional and physiological effects of treadmill training induced by buspirone, carbidopa, and L-DOPA in clenbuterol-treated paraplegic mice.

Neurorehabilitation and neural repair 20120501

The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.

Psychopharmacology 20120501

Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.

Acta psychiatrica Scandinavica 20120401

The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.

European journal of nuclear medicine and molecular imaging 20120401

The role of serotonin in the regulation of patience and impulsivity.

Molecular neurobiology 20120401

Visual social preferences of lone zebrafish in a novel environment: strain and anxiolytic effects.

Genes, brain, and behavior 20120401

An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD.

The Journal of clinical psychiatry 20120401

Asian consensus report on functional dyspepsia.

Journal of neurogastroenterology and motility 20120401

A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide.

Journal of affective disorders 20120301

Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.

European journal of medicinal chemistry 20120301

Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardee.

Basic & clinical pharmacology & toxicology 20120301

Use of buspirone and fluoxetine for breathing problems in Rett syndrome.

Pediatric neurology 20120301

Prescribing trends in veterans with posttraumatic stress disorder.

The Journal of clinical psychiatry 20120301

Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration.

Molecular psychiatry 20120201

Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.

Journal of clinical psychopharmacology 20120201

Paroxetine-induced severe sleep bruxism successfully treated with buspirone.

Clinics (Sao Paulo, Brazil) 20120201

A novel G protein-coupled receptor of Schistosoma mansoni (SmGPR-3) is activated by dopamine and is widely expressed in the nervous system.

PLoS neglected tropical diseases 20120201

Quantitative analysis of atractylenolide I in rat plasma by LC-MS/MS method and its application to pharmacokinetic study.

Journal of pharmaceutical and biomedical analysis 20120125

Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene.

Human mutation 20120101

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.

Parkinson's disease 20120101

Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Journal of drug delivery 20120101

An efficient synthesis of aripiprazole, buspirone and NAN-190 by the reductive alkylation of amines procedure.

Archiv der Pharmazie 20120101

The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

Parkinson's disease 20120101

Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey.

BMC public health 20120101

A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from generalized anxiety disorder with or without comorbidities.

International journal of yoga 20120101

Prediction of psilocybin response in healthy volunteers.

PloS one 20120101

Iontophoresis: a potential emergence of a transdermal drug delivery system.

Scientia pharmaceutica 20120101

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide.

Harm reduction journal 20120101

Resource utilization and costs before and after total joint arthroplasty.

BMC health services research 20120101

The 5HT1a receptor agonist 8-Oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium.

PloS one 20120101

Housing conditions differentially affect physiological and behavioural stress responses of zebrafish, as well as the response to anxiolytics.

PloS one 20120101

A survey of patient preferences for a placebo orodispersible tablet.

Patient preference and adherence 20120101

Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use.

Neuropsychiatric disease and treatment 20120101

Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?

Advances in pharmacological sciences 20120101

Testing homeopathy in mouse emotional response models: pooled data analysis of two series of studies.

Evidence-based complementary and alternative medicine : eCAM 20120101

An overview of the evidence and mechanisms of herb-drug interactions.

Frontiers in pharmacology 20120101

Huntington's disease.

Handbook of clinical neurology 20120101

Measures of anxiety in zebrafish (Danio rerio): dissociation of black/white preference and novel tank test.

PloS one 20120101

Treatment-resistant Schizophrenia: Evidence-based Strategies.

Mens sana monographs 20120101

Treatment-resistant depression: therapeutic trends, challenges, and future directions.

Patient preference and adherence 20120101

Optimal treatment of social phobia: systematic review and meta-analysis.

Neuropsychiatric disease and treatment 20120101

Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.

International journal of nanomedicine 20120101

Understanding and prevention of 'therapy-' induced dyskinesias.

Parkinson's disease 20120101

Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Parkinson's disease 20120101

The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.

PloS one 20120101

Quetiapine and Buspirone Both Elevate Cortical Levels of Noradrenaline and Dopamine In vivo, but Do Not have Synergistic Effects.

Frontiers in psychiatry 20120101

Interventions for treating anxiety after stroke.

The Cochrane database of systematic reviews 20111207

Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity.

Journal of psychopharmacology (Oxford, England) 20111201

Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996) 20111201

Antidepressant-like properties of sarizotan in experimental Parkinsonism.

Psychopharmacology 20111201

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified.

Journal of child and adolescent psychopharmacology 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Pharmacotherapy of anxiety disorders: a critical review.

Dialogues in clinical neuroscience 20111201

Pharmacotherapy for anxiety disorders in children and adolescents.

Dialogues in clinical neuroscience 20111201

Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.

Rapid communications in mass spectrometry : RCM 20111115

Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?

Depression and anxiety 20111101

Pharmacological treatment of generalized anxiety disorder.

Expert opinion on pharmacotherapy 20111101

Buspirone before prenatal stress protects against adverse effects of stress on emotional and inflammatory pain-related behaviors in infant rats: age and sex differences.

Brain research 20111024

A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.

Journal of clinical psychopharmacology 20111001

Patterns of avoidance behaviours in the light/dark preference test in young juvenile zebrafish: a pharmacological study.

Behavioural brain research 20110912

5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.

Neuropharmacology 20110901

Attenuation of apomorphine-induced sensitization by buspirone.

Pharmacology, biochemistry, and behavior 20110901

Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol.

Pharmacology, biochemistry, and behavior 20110901

Physiologically based pharmacokinetic modeling of intestinal first-pass metabolism of CYP3A substrates with high intestinal extraction.

Drug metabolism and disposition: the biological fate of chemicals 20110901

Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.

Gut and liver 20110901

Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.

Psychiatry investigation 20110901

Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.

Current neuropharmacology 20110901

Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20110801

Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma.

Journal of pharmaceutical and biomedical analysis 20110715

Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

Journal of medicinal chemistry 20110714

Phasic and sustained fear are pharmacologically dissociable in rats.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110701

Species independence in brain tissue binding using brain homogenates.

Drug metabolism and disposition: the biological fate of chemicals 20110701

The effect of component of microemulsions on transdermal delivery of buspirone hydrochloride.

Journal of pharmaceutical sciences 20110601

Emerging drugs for functional dyspepsia.

Expert opinion on emerging drugs 20110601

[Serotonin receptor 1A-modulated dephosphorylation of glycine receptor α3: a new molecular mechanism of breathing control for compensation of opioid-induced respiratory depression without loss of analgesia].

Schmerz (Berlin, Germany) 20110601

Drug therapies for tardive dyskinesia: Part 1.

Journal of psychosocial nursing and mental health services 20110601

Adverse effects of oral nonstimulant psychotropic medications in young children reported to a regional poison center.

Clinical toxicology (Philadelphia, Pa.) 20110601

Covariation of EEG synchronization and emotional state as modified by anxiolytics.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20110601

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

Journal of medicinal chemistry 20110512

Simultaneous quantification of loureirin A and loureirin B in rat urine, feces, and bile by HPLC-MS/MS method and its application to excretion study.

Analytical and bioanalytical chemistry 20110501

Analgesic and antineuropathic drugs acting through central cholinergic mechanisms.

Recent patents on CNS drug discovery 20110501

Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice.

Prescrire international 20110501

Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats.

Behavioural brain research 20110415

Development and evaluation of a multiple-plate fraction collector for sample processing: application to radioprofiling in drug metabolism studies.

Journal of pharmaceutical and biomedical analysis 20110405

Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress.

Investigative ophthalmology & visual science 20110404

Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110401

The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.

The journal of sexual medicine 20110401

Pharmacological analysis of zebrafish (Danio rerio) scototaxis.

Progress in neuro-psychopharmacology & biological psychiatry 20110330

Vogel conflict test: sex differences and pharmacological validation of the model.

Behavioural brain research 20110317

Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.

Journal of endocrinological investigation 20110301

Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications.

European journal of nuclear medicine and molecular imaging 20110301

Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.

Psychiatry investigation 20110301

Acute tryptophan depletion attenuates conscious appraisal of social emotional signals in healthy female volunteers.

Psychopharmacology 20110201

Maternal buspirone protects against the adverse effects of in utero stress on emotional and pain-related behaviors in offspring.

Physiology & behavior 20110201

Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to α1-adrenergic receptors among arylpiperazine derivatives of phenytoin.

Bioorganic & medicinal chemistry 20110201

Application of a fluorescence-based continuous-flow bioassay to screen for diversity of cytochrome P450 BM3 mutant libraries.

Journal of biomolecular screening 20110201

Breast enlargement associated with low dose olanzapine.

Indian journal of pharmacology 20110201

[Effects of chronic buspirone treatment on female mice exposed to the long-lasting psychoemotional influence].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20110201

The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats.

Addiction biology 20110101

Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box.

Behavioural brain research 20110101

Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.

The journal of sexual medicine 20110101

SSR181507, a dopamine D₂ receptor and 5-HT(₁A) receptor ligand: evidence for mixed anxiolytic- and antidepressant-like activities.

Pharmacology, biochemistry, and behavior 20110101

Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior.

Journal of neurochemistry 20110101

Activation of the central serotonergic system in response to delayed but not omitted rewards.

The European journal of neuroscience 20110101

5-HT receptors mediate lineage-dependent effects of serotonin on adult neurogenesis in Procambarus clarkii.

Neural development 20110101

Influence of enriched environment on viral encephalitis outcomes: behavioral and neuropathological changes in albino Swiss mice.

PloS one 20110101

Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.

Trials 20110101

Megafaunal community structure of Andaman seamounts including the Back-arc Basin--a quantitative exploration from the Indian Ocean.

PloS one 20110101

Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?

Annals of general psychiatry 20110101

Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.

BMC complementary and alternative medicine 20110101

Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model.

International journal of nanomedicine 20110101

Pharmacological treatment of cannabis dependence.

Current pharmaceutical design 20110101

A meta-analysis of studies of treatments for feline urine spraying.

PloS one 20110101

Targeting nicotine addiction: the possibility of a therapeutic vaccine.

Drug design, development and therapy 20110101

Postural control in bipolar disorder: increased sway area and decreased dynamical complexity.

PloS one 20110101

Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.

Reviews in the neurosciences 20110101

Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.

Molecular brain 20110101

Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective.

Pathology research international 20110101

Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

Journal of pharmacy & bioallied sciences 20110101

Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome.

Frontiers in pharmacology 20110101

Duloxetine-induced nocturnal bruxism resolved by buspirone: case report.

Clinical neuropharmacology 20110101

Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting - a retrospective case series.

Journal of pharmacology & pharmacotherapeutics 20110101

Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.

Frontiers in systems neuroscience 20110101

Antinociceptive activity of the chloroform fraction of Dioclea virgata (Rich.) Amshoff (Fabaceae) in mice.

Journal of biomedicine & biotechnology 20110101

Expression and function of serotonin 2A and 2B receptors in the mammalian respiratory network.

PloS one 20110101

Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient mice.

PloS one 20110101

Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.

Therapeutics and clinical risk management 20110101

Histaminergic mechanisms for modulation of memory systems.

Neural plasticity 20110101

Identification of novel functional inhibitors of acid sphingomyelinase.

PloS one 20110101

Gelsemium sempervirens and Animal Behavioral Models.

Frontiers in neurology 20110101

Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research.

The Journal of neuropsychiatry and clinical neurosciences 20110101

Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.

The primary care companion for CNS disorders 20110101

Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.

Pharmacological reports : PR 20110101

Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial.

Critical care (London, England) 20110101

Extended course of repetitive trans-cranial magnetic stimulation therapy and a complicated case of obsessive-compulsive disorder.

Indian journal of psychological medicine 20110101

Generalised anxiety disorder.

BMJ clinical evidence 20110101

Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.

Journal of biomedical science 20110101

Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence.

Advances in pharmacological sciences 20110101

An fMRI study on the role of serotonin in reactive aggression.

PloS one 20110101

Exploration of sex differences in Rhes effects in dopamine mediated behaviors.

Neuropsychiatric disease and treatment 20110101

Subchronic treatment with fluoxetine attenuates the proerectile effect of Aspidosperma ulei Markgr (Apocyanaceae).

Indian journal of pharmacology 20110101

Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study.

BMC psychiatry 20110101

Therapeutic hypothermia in stroke and traumatic brain injury.

Frontiers in neurology 20110101

Augmentation effect of repetitive transcranial magnetic stimulation over the supplementary motor cortex in treatment refractory patients with obsessive compulsive disorder.

Indian journal of psychiatry 20110101

Effect of pomegranate pretreatment on the oral bioavailability of buspirone in male albino rabbits.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

5-HT(1A) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews 20101208

Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.

Journal of liposome research 20101201

Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.

Child psychiatry and human development 20101201

Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome.

Journal of pain and symptom management 20101201

Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray.

Experimental neurology 20101201

A predictive ligand-based Bayesian model for human drug-induced liver injury.

Drug metabolism and disposition: the biological fate of chemicals 20101201

Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N-phenylbenzo[b]thiophene-3-carboxamide.

European journal of medicinal chemistry 20101201

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.

Journal of clinical psychopharmacology 20101201

An interesting case of serotonin syndrome precipitated by escitalopram.

Indian journal of pharmacology 20101201

Pregnancy in woman with spinal cord stimulator for complex regional pain syndrome: a case report and review of the literature.

The Korean journal of pain 20101201

[Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies].

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20101201

Brain serotonergic circuitries.

Dialogues in clinical neuroscience 20101201

The serotonin syndrome-the need for physician's awareness.

International journal of emergency medicine 20101201

Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

Healthcare informatics research 20101201

Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys.

Drug metabolism and disposition: the biological fate of chemicals 20101101

Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.

Current drug metabolism 20101101

QEEG Measures in Huntington's Disease: A Pilot Study.

PLoS currents 20101025

Evaluation of antianxiety and sedative effects of essential oil of Ducrosia anethifolia in mice.

Clinics (Sao Paulo, Brazil) 20101001

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Cancer prevention research (Philadelphia, Pa.) 20100901

Treatment of Irritability in Huntington's Disease.

Current treatment options in neurology 20100901

Conversion phenomenon during the induction period of general anesthesia -A case report-.

Korean journal of anesthesiology 20100901

A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Current neuropharmacology 20100901

Graft-induced dyskinesias in Parkinson's disease: what is it all about?

Cell stem cell 20100806

Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus.

The international journal of neuropsychopharmacology 20100801

5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia.

Psychopharmacology 20100801

Identification and quantification of 30 antipsychotics in blood using LC-MS/MS.

Journal of mass spectrometry : JMS 20100801

Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study.

Brain research 20100723

Antidepressant-like effect of Salvia sclarea is explained by modulation of dopamine activities in rats.

Journal of ethnopharmacology 20100706

Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice.

Psychopharmacology 20100701

The pharmacologic treatment of anxiety disorders: a review of progress.

The Journal of clinical psychiatry 20100701

Effect of acute and chronic buspirone administration on communicativeness of mice with experience of defeats in social conflicts.

Bulletin of experimental biology and medicine 20100701

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

Science translational medicine 20100630

Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.

Fundamental & clinical pharmacology 20100601

Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation.

Drug metabolism and disposition: the biological fate of chemicals 20100601

Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box-Behnken statistical design.

AAPS PharmSciTech 20100601

Drug treatment of obsessive-compulsive disorder.

Dialogues in clinical neuroscience 20100601

Body dysmorphic disorder.

Dialogues in clinical neuroscience 20100601

Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment.

Psychoneuroendocrinology 20100501

Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice.

Journal of neuroscience methods 20100430

Buspirone-induced changes in the serotonergic and non-serotonergic cells in the dorsal raphe nucleus of rats.

Neuroscience letters 20100405

Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.

Journal of psychopharmacology (Oxford, England) 20100401

Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder.

Psychiatry and clinical neurosciences 20100401

Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).

Bioorganic & medicinal chemistry letters 20100401

Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy.

Biotechnology journal 20100401

Buspirone attenuates tolerance to analgesic effect of morphine in mice with skin cancer.

Pakistan journal of pharmaceutical sciences 20100401

Therapeutic hypothermia for acute ischemic stroke.

Expert review of cardiovascular therapy 20100401

[Effects of prenatal influences of buspirone and stress on indices of inflammatory pain response and depressive behaviour in adult rats].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20100401

Effects of serotonin agonists and doxapram on respiratory depression and hypoxemia in etorphine-immobilized impala (Aepyceros melampus).

Journal of wildlife diseases 20100401

The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation.

Behavioural brain research 20100317

Oxidative stress in rat hippocampus caused by pilocarpine-induced seizures is reversed by buspirone.

Brain research bulletin 20100316

Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.

Biological psychiatry 20100315

Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies.

International journal of pharmaceutics 20100315

5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.

European archives of psychiatry and clinical neuroscience 20100301

Effects of amantadine on circulating neurotransmitters in healthy subjects.

Journal of neural transmission (Vienna, Austria : 1996) 20100301

Past, present and future therapeutics for cerebellar ataxias.

Current neuropharmacology 20100301

Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds.

FEBS letters 20100219

Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.

Journal of medicinal chemistry 20100211

Effect of serotonergic system on AVP secretion induced by physical exercise.

Neuropeptides 20100201

Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.

Headache 20100201

The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics.

Pharmacology, biochemistry, and behavior 20100201

Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates.

BMC neuroscience 20100101

Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.

The Journal of neuropsychiatry and clinical neurosciences 20100101

Identification of molecular targets associated with ethanol toxicity and implications in drug development.

Current pharmaceutical design 20100101

Mouse models of apnea: strain differences in apnea expression and its pharmacologic and genetic modification.

Advances in experimental medicine and biology 20100101

Aggression and anxiety: social context and neurobiological links.

Frontiers in behavioral neuroscience 20100101

Impact of resilience enhancing programs on youth surviving the Beslan school siege.

Child and adolescent psychiatry and mental health 20100101

Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.

Arzneimittel-Forschung 20100101

Medications acting on the serotonergic system for the treatment of alcohol dependent patients.

Current pharmaceutical design 20100101

Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats.

Pharmacological reports : PR 20100101

Current trends in drug treatment of obsessive-compulsive disorder.

Neuropsychiatric disease and treatment 20100101

Application of a naturalistic psychogenic stressor in periadolescent mice: effect on serum corticosterone levels differs by strain but not sex.

BMC research notes 20100101

Line bisection performance in patients with generalized anxiety disorder and treatment-resistant depression.

International journal of medical sciences 20100101

Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.

Tobacco induced diseases 20100101

Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

Frontiers in neuroscience 20100101

Adult zebrafish as a model organism for behavioural genetics.

BMC neuroscience 20100101

Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.

Primary care companion to the Journal of clinical psychiatry 20100101

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.

BMC medicine 20100101

Principal component analysis of HPLC retention data and molecular modeling structural parameters of cardiovascular system drugs in view of their pharmacological activity.

International journal of molecular sciences 20100101

The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients.

BMC neurology 20100101

Getting the balance right: Established and emerging therapies for major depressive disorders.

Neuropsychiatric disease and treatment 20100101

Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.

Nutrition journal 20100101

Tricyclic antidepressants and headaches: systematic review and meta-analysis.

BMJ (Clinical research ed.) 20100101

What alternatives to first-line therapy for depression are effective?

The Journal of clinical psychiatry 20100101

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?

BMC medicine 20100101

A new strategy for antidepressant prescription.

Frontiers in neuroscience 20100101

Acute administration of clozapine and risperidone altered dopamine metabolism more in rat caudate than in nucleus accumbens: a dose-response relationship.

Scientia pharmaceutica 20100101

Effect of itraconazole on the pharmacokinetics of diclofenac in beagle dogs.

Scientia pharmaceutica 20100101

Fourth revolution in psychiatry - Addressing comorbidity with chronic physical disorders.

Indian journal of psychiatry 20100101

The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis.

Frontiers in neurology 20100101

Integrated management strategies for chronic obstructive pulmonary disease.

Journal of multidisciplinary healthcare 20100101

A Simple RP-HPLC Method for Quantitation of Itopride HCl in Tablet Dosage Form.

Journal of young pharmacists : JYP 20100101

The geriatric population and psychiatric medication.

Mens sana monographs 20100101

Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome.

Diabetes, metabolic syndrome and obesity : targets and therapy 20100101

Antidepressant-associated sexual dysfunction: impact, effects, and treatment.

Drug, healthcare and patient safety 20100101

Patent protection strategies.

Journal of pharmacy & bioallied sciences 20100101

Indian Psychiatry and Indian Journal of Psychiatry - A journey.

Indian journal of psychiatry 20100101

An overview of Indian research in anxiety disorders.

Indian journal of psychiatry 20100101

Psychological interventions in the management of common skin conditions.

Psychology research and behavior management 20100101

Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

Effect of pomegranate juice pre-treatment on the transport of carbamazepine across rat intestine.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

A sensitive LC-MS/MS method to quantify loureirin B in rat plasma with application to preclinical pharmacokinetic studies.

Journal of pharmaceutical and biomedical analysis 20091205

Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.

Bioorganic & medicinal chemistry letters 20091201

PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety.

Pharmacology, biochemistry, and behavior 20091101

Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety.

Pharmacology, biochemistry, and behavior 20091101

Defeating normal thermoregulatory defenses: induction of therapeutic hypothermia.

Stroke 20091101

A placebo-controlled trial of buspirone for the treatment of marijuana dependence.

Drug and alcohol dependence 20091101

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

Psychiatric services (Washington, D.C.) 20091101

The effects of buspirone and diazepam on aversive context- and social isolation-induced ultrasonic vocalisation.

Physiology & behavior 20091019

Physical binding pocket induction for affinity prediction.

Journal of medicinal chemistry 20091008

Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.

The Journal of pharmacology and experimental therapeutics 20091001

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

Psychopharmacology 20091001

Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.

Biochemical pharmacology 20090915

Serotonin targets inhibitory synapses to induce modulation of network functions.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20090912

Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.

Rapid communications in mass spectrometry : RCM 20090901

Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.

The Journal of pharmacy and pharmacology 20090901

Development of high performance liquid chromatography method for buspirone in rabbit serum: Application to pharmacokinetic study.

Analytica chimica acta 20090811

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.

European journal of nuclear medicine and molecular imaging 20090801

Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.

Psychopharmacology 20090801

STAR*D: revising conventional wisdom.

CNS drugs 20090801

Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.

Human psychopharmacology 20090801

Carboxy group derivatization for enhanced electron-transfer dissociation mass spectrometric analysis of phosphopeptides.

Proteomics 20090801

Classification of 5-HT(1A) receptor ligands on the basis of their binding affinities by using PSO-Adaboost-SVM.

International journal of molecular sciences 20090801

The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Psychopharmacology 20090701

Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.

Psychopharmacology 20090701

Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Psychopharmacology 20090701

Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers.

Anesthesiology 20090701

Thermoregulatory defense mechanisms.

Critical care medicine 20090701

Gabapentin-induced delirium and dependence.

Journal of psychiatric practice 20090701

Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features.

International journal of environmental research and public health 20090701

Inhibitory effect of fentanyl on phenylephrine-induced contraction of the rat aorta.

Yonsei medical journal 20090630

Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.

Toxicology and applied pharmacology 20090615

The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica).

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090601

Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model.

Planta medica 20090601

Proposal of buspirone collision-induced dissociation rearrangement by exact mass measurements.

Rapid communications in mass spectrometry : RCM 20090601

Spectroscopic study of the reaction mechanism of buspirone interaction with iodine and tetracyanoethylene reagents and its applications.

Drug testing and analysis 20090601

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.

Journal of clinical medicine research 20090601

Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.

Journal of neuroscience methods 20090530

Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.

Journal of medicinal chemistry 20090528

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

The international journal of neuropsychopharmacology 20090501

Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.

Pharmacology, biochemistry, and behavior 20090501

Ice-cold saline for the induction of mild hypothermia in patients with acute ischemic stroke: a pilot study.

Stroke 20090501

Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.

The Journal of pharmacy and pharmacology 20090501

Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.

Psychopharmacology 20090401

Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.

European journal of pharmacology 20090401

Algorithm for thorough background subtraction of high-resolution LC/MS data: application to obtain clean product ion spectra from nonselective collision-induced dissociation experiments.

Analytical chemistry 20090401

[Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].

L'Encephale 20090401

The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.

Journal of clinical gastroenterology 20090301

Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats.

Alcoholism, clinical and experimental research 20090301

Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers.

Planta medica 20090301

Synthesis and pharmacological evaluation of new arylpiperazines N-[4-[4-(aryl) piperazine-1-yl]-phenyl]-amine derivatives: putative role of 5-HT1A receptors.

Bioorganic & medicinal chemistry 20090301

Involvement of the subthalamic nucleus in engagement with behaviourally relevant stimuli.

The European journal of neuroscience 20090301

Psychoactive medication and traffic safety.

International journal of environmental research and public health 20090301

Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists.

Bioorganic & medicinal chemistry letters 20090215

Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers.

Journal of pharmaceutical sciences 20090201

The influence of an ethylene spacer on the 5-HT(1A) and 5-HT(2A) receptor affinity of arylpiperazine derivatives of amides with N-acylated amino acids and 3-differently substituted pyrrolidine-2,5-diones.

European journal of medicinal chemistry 20090201

Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study.

Neuropharmacology 20090201

Prevalence of ergot derivatives in natural ryegrass pastures: detection and pathogenicity in the horse.

Theriogenology 20090201

Antinociceptive activity of Tilia americana var. mexicana inflorescences and quercetin in the formalin test and in an arthritic pain model in rats.

Neuropharmacology 20090201

Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy.

Indian journal of pharmacology 20090201

Synthesis and serotonin receptor activity of the arylpiperazine alkyl/propoxy derivatives of new azatricycloundecanes.

European journal of medicinal chemistry 20090101

Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient.

Spinal cord 20090101

5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography.

Alcohol and alcoholism (Oxford, Oxfordshire) 20090101

Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats.

Neurochemistry international 20090101

[Alternative agents used in ADHD].

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20090101

Augmentation strategies for treatment-resistant depression.

Current opinion in psychiatry 20090101

Worsening of bruxism with atomoxetine: a case report.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20090101

Refractory generalized anxiety disorder.

The Journal of clinical psychiatry 20090101

Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats.

Neuropharmacology 20090101

Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.

Neuropharmacology 20090101

Obsessive-compulsive disorder and related disorders: a comprehensive survey.

Annals of general psychiatry 20090101

Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue.

BMC gastroenterology 20090101

Effect of buspirone on thermal sensory and pain thresholds in human volunteers.

BMC clinical pharmacology 20090101

Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly?

BMC geriatrics 20090101

Field torso-warming modalities: a comparative study using a human model.

Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 20090101

[STAR* D study: searching strategies regarding lack of response to an SSRI].

Vertex (Buenos Aires, Argentina) 20090101

Pharmacotherapy for cannabis dependence: how close are we?

CNS drugs 20090101

Duloxetine for the treatment of generalized anxiety disorder: a review.

Neuropsychiatric disease and treatment 20090101

Reduction of the number of new cells reaching olfactory bulbs impairs olfactory perception in the adult opossum.

Acta neurobiologiae experimentalis 20090101

Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder.

BMC geriatrics 20090101

Interactions between herbal medicines and prescribed drugs: an updated systematic review.

Drugs 20090101

Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression.

Psychotherapy and psychosomatics 20090101

Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 20090101

More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.

Indian journal of psychiatry 20090101

A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.

Clinical pharmacokinetics 20090101

A systematic review of augmentation strategies for patients with major depressive disorder.

Psychopharmacology bulletin 20090101

Drugs associated with more suicidal ideations are also associated with more suicide attempts.

PloS one 20090101

Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation.

PloS one 20090101

Emotional reactivity and cognitive performance in aversively motivated tasks: a comparison between four rat strains.

Behavioral and brain functions : BBF 20090101

Depression with panic episodes and coronary vasospasm.

Cardiovascular psychiatry and neurology 20090101

Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation.

Oxidative medicine and cellular longevity 20090101

Computerized assessment of social approach behavior in mouse.

Frontiers in behavioral neuroscience 20090101

Duloxetine in the treatment of generalized anxiety disorder.

International journal of general medicine 20090101

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy.

Core evidence 20090101

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder.

International journal of women's health 20090101

Behavioral and psychological symptoms of dementia and their management.

Indian journal of psychiatry 20090101

Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?

Behavioural brain research 20081216

Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response.

Progress in neuro-psychopharmacology & biological psychiatry 20081212

Influence of buspirone on gastric sensorimotor function in man.

Alimentary pharmacology & therapeutics 20081201

Prokinetics and fundic relaxants in upper functional GI disorders.

Current opinion in pharmacology 20081201

Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system.

Planta medica 20081201

Towards achieving remission in the treatment of depression.

Dialogues in clinical neuroscience 20081201

Treatment strategies to improve and sustain remission in major depressive disorder.

Dialogues in clinical neuroscience 20081201

Incomplete remission in depression: role of psychiatric and somatic comorbidity.

Dialogues in clinical neuroscience 20081201

Diffusion tensor imaging of frontal lobe in autism spectrum disorder.

Cerebral cortex (New York, N.Y. : 1991) 20081101

Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081101

Resistive polymer versus forced-air warming: comparable heat transfer and core rewarming rates in volunteers.

Anesthesia and analgesia 20081101

The molecular interactions of buspirone analogues with the serotonin transporter.

Bioorganic & medicinal chemistry 20081015

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Journal of medicinal chemistry 20081009

Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.

Advances in therapy 20081001

Dose-dependent response of central dopaminergic systems to buspirone in mice.

Indian journal of experimental biology 20081001

The role of duloxetine in the treatment of anxiety disorders.

Neuropsychiatric disease and treatment 20081001

Augmentation treatment in major depressive disorder: focus on aripiprazole.

Neuropsychiatric disease and treatment 20081001

Pharmacodynamic interaction of the sedative effects of Ternstroemia pringlei (Rose) Standl. with six central nervous system depressant drugs in mice.

Journal of ethnopharmacology 20080902

Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.

Chemical research in toxicology 20080901

Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Current neuropharmacology 20080901

The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.

Journal of the neurological sciences 20080815

Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.

Journal of medicinal chemistry 20080814

Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains.

Journal of applied physiology (Bethesda, Md. : 1985) 20080801

Psychiatric disorders and traumatic brain injury.

Neuropsychiatric disease and treatment 20080801

Fluoxetine overdose-induced seizure.

The western journal of emergency medicine 20080801

Post-sigh breathing behavior and spontaneous pauses in the C57BL/6J (B6) mouse.

Respiratory physiology & neurobiology 20080731

Buspirone induced acute and chronic changes of neural activation in the periaqueductal gray of rats.

Neuroscience 20080731

Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080701

Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20080601

Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080601

In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone.

Toxicological sciences : an official journal of the Society of Toxicology 20080601

Apneusis responding to buspirone in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England) 20080601

Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.

The AAPS journal 20080601

Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Clinical interventions in aging 20080601

Validating an Ataxia Functional Composite Scale in spinocerebellar ataxia.

Journal of the neurological sciences 20080515

Buspirone and serotonin in spinocerebellar ataxia.

Journal of the neurological sciences 20080515

Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition.

Behavioural pharmacology 20080501

How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.

Journal of psychiatric practice 20080501

Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.

Die Pharmazie 20080501

Psychiatric issues in renal failure and dialysis.

Indian journal of nephrology 20080401

Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.

Brain research bulletin 20080328

Location and orientation of serotonin receptor 1a agonists in model and complex lipid membranes.

The Journal of biological chemistry 20080321

Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.

European journal of nuclear medicine and molecular imaging 20080301

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models.

Pharmacology, biochemistry, and behavior 20080301

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

The American journal of psychiatry 20080301

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

European journal of nuclear medicine and molecular imaging 20080301

Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.

Body image 20080301

Quantitation of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS-MS.

Journal of analytical toxicology 20080301

Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.

Expert review of neurotherapeutics 20080301

End of life care in chronic obstructive pulmonary disease: in search of a good death.

International journal of chronic obstructive pulmonary disease 20080301

Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.

European journal of pharmacology 20080226

Pharmacological management of panic disorder.

Neuropsychiatric disease and treatment 20080201

Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs.

Pharmacology, biochemistry, and behavior 20080101

The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.

Pharmacology, biochemistry, and behavior 20080101

Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.

Pharmacology, biochemistry, and behavior 20080101

Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.

Basic & clinical pharmacology & toxicology 20080101

Buspirone for autistic disorder in a woman with an intellectual disability.

The Annals of pharmacotherapy 20080101

Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.

Journal of psychiatric practice 20080101

Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.

Malaria journal 20080101

Effects of midazolam and buspirone on in vivo concentration of amino acids and monoamine metabolites in the rat hippocampus.

Pharmacological reports : PR 20080101

Failed therapy and directions for the future in dyspepsia.

Digestive diseases (Basel, Switzerland) 20080101

Context and strain-dependent behavioral response to stress.

Behavioral and brain functions : BBF 20080101

Clinical drugs that interact with St. John's wort and implication in drug development.

Current pharmaceutical design 20080101

Effect of buspirone on the behavioral regulation of rats in low versus high anxiety conditions.

Arzneimittel-Forschung 20080101

Predatory stress as an experimental strategy to measure fear and anxiety-related behaviors in non-human primates.

Reviews in the neurosciences 20080101

Acoustic startle reflex in rhesus monkeys: a review.

Reviews in the neurosciences 20080101

Brain serotonin and dopamine modulators, perceptual responses and endurance performance during exercise in the heat following creatine supplementation.

Journal of the International Society of Sports Nutrition 20080101

Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.

PloS one 20080101

Imaging the neural circuitry and chemical control of aggressive motivation.

BMC neuroscience 20080101

Marijuana neurobiology and treatment.

Substance abuse 20080101

Rapid and sensitive characterization of the metabolite formation enzyme kinetics of radiolabeled drugs using stop-flow liquid radiochromatography.

Drug metabolism letters 20080101

Panic disorder.

BMJ clinical evidence 20080101

Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis.

Current drug metabolism 20071201

Management of the behavioral and psychological symptoms of dementia.

Clinical interventions in aging 20071201

Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors.

Acta biologica Hungarica 20071201

Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important?

Current neuropharmacology 20071201

[Pathologic worry].

MMW Fortschritte der Medizin 20071115

Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man.

Pharmaceutical research 20071101

Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor.

Journal of psychopharmacology (Oxford, England) 20071101

Behavioral response to emotional stress in rabbits: role of serotonin and serotonin2A receptors.

Behavioural pharmacology 20071101

Behavioural and pharmacological specificity of the effects of drugs on punished schedule-induced polydipsia.

Behavioural pharmacology 20071101

[Pharmacological therapy for therapy-resistant depression. New developments].

Der Nervenarzt 20071101

An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.

Journal of psychopharmacology (Oxford, England) 20071101

[Generalized anxiety disorder (GAD)--diagnosis and therapy].

Medizinische Monatsschrift fur Pharmazeuten 20071101

Response surface analysis of solution-mediated polymorphic transformation of buspirone hydrochloride.

Journal of pharmaceutical and biomedical analysis 20071018

Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats.

Psychopharmacology 20071001

Dose related effects of buspirone on serum electrolyte balance, plasma osmolality and systolic blood pressure (SBP) in rats.

Pakistan journal of pharmaceutical sciences 20071001

Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans.

Biopharmaceutics & drug disposition 20071001

alpha1-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats.

Naunyn-Schmiedeberg's archives of pharmacology 20071001

Augmentation strategies for treatment-resistant depression: a literature review.

Journal of clinical pharmacy and therapeutics 20071001

The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.

European archives of psychiatry and clinical neuroscience 20071001

Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20071001

Pharmacological causes of hyperprolactinemia.

Therapeutics and clinical risk management 20071001

[Resistant depression].

Revue medicale suisse 20070919

Treatment of spinocerebellar ataxia with buspirone.

Journal of the neurological sciences 20070915

Survey of management of acquired nystagmus in the United Kingdom.

Eye (London, England) 20070901

Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.

Alcoholism, clinical and experimental research 20070901

Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.

Schizophrenia research 20070901

Neurotoxic syndrome developed after taking sertraline and risperidone.

Journal of clinical neurology (Seoul, Korea) 20070901

6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats.

Drug metabolism and disposition: the biological fate of chemicals 20070801

Hormonal response to buspirone is not impaired in major depression.

Human psychopharmacology 20070801

Glutamate and anxiety disorders.

Current psychiatry reports 20070801

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.

Neuropsychiatric disease and treatment 20070801

Simultaneous determination of metabolic stability and identification of buspirone metabolites using multiple column fast liquid chromatography time-of-flight mass spectrometry.

Journal of chromatography. A 20070713

Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070701

Solubility analysis of buspirone hydrochloride polymorphs: measurements and prediction.

International journal of pharmaceutics 20070629

Mass spectrometric investigation of buspirone drug in comparison with thermal analyses and MO-calculations.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070601

Unintentional onset of anorexia nervosa.

Eating and weight disorders : EWD 20070601

Frontal-subcortical circuitry and behavior.

Dialogues in clinical neuroscience 20070601

Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.

Progress in neuro-psychopharmacology & biological psychiatry 20070509

[Augmentation strategies for therapy resistant depression - a review].

Psychiatrische Praxis 20070501

Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.

Psychoneuroendocrinology 20070501

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.

The American journal of psychiatry 20070501

Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.

Pharmacology, biochemistry, and behavior 20070501

Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic?

Journal of psychiatric practice 20070501

Effects of buspirone on the immediate positive and delayed negative properties of intravenous cocaine as measured in the conditioned place preference test.

Pharmacology, biochemistry, and behavior 20070501

Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole blood.

Journal of analytical toxicology 20070501

Polycystic ovary syndrome and hyperprolactinemia are distinct entities.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070501

Premenstrual syndrome.

BMJ clinical evidence 20070501

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model.

Behavioural brain research 20070416

Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.

Journal of ethnopharmacology 20070404

Treatment of generalized anxiety disorder.

Neuropsychiatric disease and treatment 20070401

Role of pregabalin in the treatment of generalized anxiety disorder.

Neuropsychiatric disease and treatment 20070401

Quantitative and molecular analysis of buspirone hydrochloride polymorphs.

Journal of pharmaceutical sciences 20070301

Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition.

The Journal of pharmacology and experimental therapeutics 20070301

Lack of deleterious effects of buspirone on cognition in healthy male volunteers.

Journal of psychopharmacology (Oxford, England) 20070301

Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study.

Behavioural pharmacology 20070301

Screening of 5-HT1A receptor antagonists using molecularly imprinted polymers.

Journal of the American Chemical Society 20070214

Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone.

Biological psychiatry 20070201

Evaluation of anxiolytic potential of Celastrus oil in rat models of behaviour.

Fitoterapia 20070201

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.

Psychopharmacology 20070201

The effect of buspirone on normal and hypoarousal-driven abnormal aggression in rats.

Progress in neuro-psychopharmacology & biological psychiatry 20070130

The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.

Clinical pharmacology and therapeutics 20070101

Probable statin-induced testicular pain.

The Annals of pharmacotherapy 20070101

Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study.

Critical care (London, England) 20070101

Treating inhalant abuse with buspirone.

The American journal on addictions 20070101

[Pharmacological treatment of generalized anxiety disorders: rationale and limitations].

L'Encephale 20070101

The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.

Pharmacology, biochemistry, and behavior 20070101

Endocannabinoid system and synaptic plasticity: implications for emotional responses.

Neural plasticity 20070101

Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying test.

Neural plasticity 20070101

General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.

Clinical pharmacokinetics 20070101

Psychoimmunological effects of dioscorea in ovariectomized rats: role of anxiety level.

Annals of general psychiatry 20070101

The combination of buspirone and bupropion in the treatment of depression.

Psychotherapy and psychosomatics 20070101

Flow injection analysis with tubular membrane ion-selective electrode and coated wires for buspirone hydrochloride.

Annali di chimica 20070101

Augmentation strategies to increase antidepressant efficacy.

The Journal of clinical psychiatry 20070101

Medicinal importance of grapefruit juice and its interaction with various drugs.

Nutrition journal 20070101

Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity.

Critical care (London, England) 20070101

Effects of buspirone on dopamine dependent behaviours in rats.

Indian journal of physiology and pharmacology 20070101

Generalised anxiety disorder.

BMJ clinical evidence 20070101

[The role of serotonergic 2C receptors in neurobiology and treatment of eating disorders].

Psychiatrike = Psychiatriki 20070101

Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.

European journal of pharmacology 20061228

Quantification of a cytochrome P450 3A4 substrate, buspirone, in human plasma by liquid chromatography-tandem mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061205

Serotonergic modulation of murine fundic tone.

American journal of physiology. Gastrointestinal and liver physiology 20061201

Epidemiologic and clinical updates on impulse control disorders: a critical review.

European archives of psychiatry and clinical neuroscience 20061201

Effects of St. John's wort extract and single constituents on stress-induced hyperthermia in mice.

Planta medica 20061201

Strategies for managing antidepressant-induced sexual dysfunction: a review.

Current psychiatry reports 20061201

Use of a serotonin 1A receptor agonist to treat restless legs syndrome.

Journal of clinical psychopharmacology 20061201

Effects of repeated green tea catechin administration on human cytochrome P450 activity.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20061201

The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect.

Journal of clinical neurology (Seoul, Korea) 20061201

Anxiolytic effects of the aqueous extract of Uncaria rhynchophylla.

Journal of ethnopharmacology 20061124

Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.

European journal of pharmacology 20061121

Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs.

European journal of pharmacology 20061121

Modeling anxiety-like states: pharmacological characterization of the chick separation stress paradigm.

Behavioural pharmacology 20061101

Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range.

Journal of clinical pharmacology 20061101

An increased hypothermic response to buspirone in patients with major depression.

Psychopharmacology 20061001

Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.

Pharmacology, biochemistry, and behavior 20061001

5-HT-1A receptor responsiveness following subchronic administration of buspirone.

Pakistan journal of pharmaceutical sciences 20061001

Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice.

Behavioural brain research 20060925

Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat.

British journal of pharmacology 20060901

Experimental animal models for the simulation of depression and anxiety.

Dialogues in clinical neuroscience 20060901

Palliative management of refractory dyspnea in COPD.

International journal of chronic obstructive pulmonary disease 20060901

Depression in COPD--management and quality of life considerations.

International journal of chronic obstructive pulmonary disease 20060901

Effect of buspirone: An anxiolytic drug on blood glucose in humans.

Indian journal of clinical biochemistry : IJCB 20060901

Thermal effects of whole head submersion in cold water on nonshivering humans.

Journal of applied physiology (Bethesda, Md. : 1985) 20060801

Antidepressant-induced bruxism: need for buspirone?

The international journal of neuropsychopharmacology 20060801

A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20060801

After the failure of citalopram for depression, what next?

Expert opinion on pharmacotherapy 20060801

Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.

The Cochrane database of systematic reviews 20060719

Azapirones for generalized anxiety disorder.

The Cochrane database of systematic reviews 20060719

In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.

Neuropharmacology 20060701

Do antidepressants cure or create abnormal brain states?

PLoS medicine 20060701

Therapeutic options: Addressing the current dilemma.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060701

Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands.

Psychopharmacology 20060701

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

The American journal of psychiatry 20060701

Neuropharmacological effects of an ethanol extract of the Magnolia dealbata Zucc. leaves in mice.

Journal of ethnopharmacology 20060630

Depression--augmentation or switch after initial SSRI treatment.

The New England journal of medicine 20060615

An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.

Journal of medicinal chemistry 20060601

Treatment of Alzheimer's disease across the spectrum of severity.

Clinical interventions in aging 20060601

Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder.

Neuropsychiatric disease and treatment 20060601

Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3.

Journal of the American Chemical Society 20060510

Pharmacokinetics of buspirone in autistic children.

Journal of clinical pharmacology 20060501

Solid-state characterization of buspirone hydrochloride polymorphs.

Pharmaceutical research 20060501

TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice.

Pharmacology, biochemistry, and behavior 20060501

Drug therapy for obstructive sleep apnoea in adults.

The Cochrane database of systematic reviews 20060419

Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060401

Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.

Toxicological sciences : an official journal of the Society of Toxicology 20060401

Mirtazapine in bupropion-induced dyskinesias: a case report.

Movement disorders : official journal of the Movement Disorder Society 20060401

Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils.

Pharmacology, biochemistry, and behavior 20060401

Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.

Brain research bulletin 20060331

Pharmacological evaluation of the stress-induced social avoidance model of anxiety.

Brain research bulletin 20060331

Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.

European journal of pharmacology 20060327

Medication augmentation after the failure of SSRIs for depression.

The New England journal of medicine 20060323

Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying.

Life sciences 20060320

Clinical interventions for late-life anxious depression.

Clinical interventions in aging 20060301

A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments.

Neuropsychiatric disease and treatment 20060301

Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety.

Behavioural pharmacology 20060201

Automated software-guided identification of new buspirone metabolites using capillary LC coupled to ion trap and TOF mass spectrometry.

Journal of mass spectrometry : JMS 20060201

[Review of neurobehavioral effects of alcohol-related neurodevelopmental disorder in an animal model].

Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20060201

Effect of modulation of serotonergic, cholinergic, and nitrergic pathways on murine fundic size and compliance measured by ultrasonomicrometry.

American journal of physiology. Gastrointestinal and liver physiology 20060101

Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs.

Neuropharmacology 20060101

Contractile effects of 5-hydroxytryptamine and 5-carboxamidotryptamine in the equine jejunum.

British journal of pharmacology 20060101

Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.

Psychopharmacology 20060101

Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors.

Psychopharmacology 20060101

Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.

Pharmacopsychiatry 20060101

Hyper-anxiety in early sobriety: psychopharmacological treatment strategies.

Journal of psychosocial nursing and mental health services 20060101

Behavioral effects of ketamine and toxic interactions with psychostimulants.

BMC neuroscience 20060101

Rapid and highly sensitive liquid chromatography/electrospray ionization tandem mass spectrometry method for the quantitation of buspirone in human plasma: application to a pharmacokinetic study.

Rapid communications in mass spectrometry : RCM 20060101

Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors.

Clinical practice and epidemiology in mental health : CP & EMH 20060101

Buspirone for stereotypic movements in elderly with cognitive impairment.

The Journal of neuropsychiatry and clinical neurosciences 20060101

[Efficacy of buspirone and fluoxetine in short-term treatment of bulimia nervosa].

Psychiatria polska 20060101

Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

CNS drugs 20060101

Pharmacological management of Huntington's disease: an evidence-based review.

Current pharmaceutical design 20060101

Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome.

Arthritis research & therapy 20060101

Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.

Clinical neuropharmacology 20060101

Buspirone for treatment of marijuana dependence: a pilot study.

The American journal on addictions 20060101

[Neonatal buspirone modulates the intermale aggression in adult mice].

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20060101

The use of sleep aids among Emergency Medicine residents: a web based survey.

BMC health services research 20060101

Inhibition of restraint-induced neuroendocrine and serotonergic responses by buspirone in rats.

Pharmacological reports : PR 20060101

Psychiatric treatment for extremely traumatized civil war refugees from former Yugoslavia. Possibilities and limitations of integrating psychotherapy and medication.

Torture : quarterly journal on rehabilitation of torture victims and prevention of torture 20060101

5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.

European journal of pharmacology 20051205

Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus.

Neuroscience letters 20051202

Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands.

Psychopharmacology 20051201

Role of sex and sex steroids in mediating pituitary-adrenal responses to acute buspirone treatment in sheep.

Journal of neuroendocrinology 20051201

Motor effects of buspirone: Relationship with dopamine and serotonin in the striatum.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20051201

Attenuation of restraint induced behavioral deficits by buspirone and propranolol in rats.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20051201

Generalised anxiety disorder.

Clinical evidence 20051201

Combination/augmentation strategies for improving the treatment of depression.

Neuropsychiatric disease and treatment 20051201

Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.

Behavioural pharmacology 20051101

The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans.

Journal of psychopharmacology (Oxford, England) 20051101

Co-administration of fluoxetine and WAY100635 improves short-term memory function.

European journal of pharmacology 20051017

The 5-HT1A receptor and the stimulus effects of LSD in the rat.

Psychopharmacology 20051001

Antidepressant-induced adverse reactions in a patient with hemorrhagic stroke.

The Annals of pharmacotherapy 20051001

Signaling pathways involved with serotonin1A agonist-mediated neuroprotection against ethanol-induced apoptosis of fetal rhombencephalic neurons.

Brain research. Developmental brain research 20050908

Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901

Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application.

Journal of pharmaceutical and biomedical analysis 20050901

Buspirone in Rett syndrome respiratory dysfunction.

Brain & development 20050901

Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.

Psychopharmacology 20050901

Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.

Headache 20050901

Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney.

The AAPS journal 20050901

Use of buspirone and enrichment to manage aberrant behavior in an American badger (Taxidea taxus).

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20050901

Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.

Neuropsychiatric disease and treatment 20050901

Pharmacologic treatment options for hypoactive sexual desire disorder.

Women's health (London, England) 20050901

Differential distribution of functional alph}1-adrenergic receptor subtypes along the rat tail artery.

The Journal of pharmacology and experimental therapeutics 20050801

Hybrid triple quadrupole-linear ion trap mass spectrometry in fragmentation mechanism studies: application to structure elucidation of buspirone and one of its metabolites.

Journal of mass spectrometry : JMS 20050801

Postnatal treatment with NAN-190 but not with 5-HT1A receptor agonists retards growth of the rat brain.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20050801

In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.

European journal of pharmacology 20050711

Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.

Psychopharmacology 20050701

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

Experimental neurology 20050701

The place of partial agonism in psychiatry: recent developments.

Journal of psychopharmacology (Oxford, England) 20050701

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.

PLoS medicine 20050701

Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats.

Indian journal of experimental biology 20050701

New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects.

Bioorganic & medicinal chemistry letters 20050615

Evidence-based pharmacotherapy of Generalized Anxiety Disorder.

The international journal of neuropsychopharmacology 20050601

Efficacy of buspirone in the treatment of opioid withdrawal.

Journal of clinical psychopharmacology 20050601

Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats.

Progress in neuro-psychopharmacology & biological psychiatry 20050601

Prediction of genotoxicity of chemical compounds by statistical learning methods.

Chemical research in toxicology 20050601

The neuropsychiatry of Parkinson's disease.

Minerva medica 20050601

Temperament and character inventory and pharmacotherapeutic outcome in bulimia nervosa.

Eating and weight disorders : EWD 20050601

Effects of midazolam on the expression of conditioned taste aversion in rats.

Brain research 20050510

Respiratory abnormalities resulting from midcervical spinal cord injury and their reversal by serotonin 1A agonists in conscious rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20050504

Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding.

Journal of psychopharmacology (Oxford, England) 20050501

Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague-Dawley rats.

Pharmacology, biochemistry, and behavior 20050501

Isobolographic analysis of the sedative interaction between six central nervous system depressant drugs and Valeriana edulis hydroalcoholic extract in mice.

The Journal of pharmacy and pharmacology 20050501

Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.

Methods and findings in experimental and clinical pharmacology 20050501

Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.

Drug metabolism and disposition: the biological fate of chemicals 20050401

Evidence for a spinal serotonergic control of the peripheral inflammation in the rat.

Life sciences 20050401

Altered neuroendocrine response and gastric dysmotility in the Flinders Sensitive Line rat.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20050401

Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP).

Biological & pharmaceutical bulletin 20050401

The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction.

Pharmacogenetics and genomics 20050401

Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin.

International journal of pharmaceutics 20050323

Antihypertensive effect of 5-HT1A agonist buspirone and 5-HT2B antagonists in experimentally induced hypertension in rats.

Pharmacology 20050301

Serotonergic modulation of carbachol-induced rhythmic activity in hippocampal slices.

Neuropharmacology 20050301

Cyp2D6 catalyzes 5-hydroxylation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of several psychoactive drugs, in human liver microsomes.

Drug metabolism and disposition: the biological fate of chemicals 20050201

Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.

Drug metabolism and disposition: the biological fate of chemicals 20050201

The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques.

Comparative medicine 20050201

Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.

European journal of pharmacology 20050131

Involvement of serotonin1A receptors in cardiovascular responses to stress: a radio-telemetry study in four rat strains.

European journal of pharmacology 20050110

Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

BMC psychiatry 20050101

Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.

The Journal of clinical psychiatry 20050101

Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.

Comprehensive psychiatry 20050101

Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

Drugs & aging 20050101

Buccal permeation of buspirone: mechanistic studies on transport pathways.

Journal of pharmaceutical sciences 20050101

Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia.

The Journal of neuropsychiatry and clinical neurosciences 20050101

Treatment of cerebellar ataxia with 5-HT1A agonist.

Cerebellum (London, England) 20050101

Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss.

Nordic journal of psychiatry 20050101

The role of buspirone for the treatment of cerebellar ataxia in an older individual.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20050101

Potentiation strategies for treatment-resistant depression.

Acta psychiatrica Scandinavica. Supplementum 20050101

Efficient single nucleotide polymorphism discovery in laboratory rat strains using wild rat-derived SNP candidates.

BMC genomics 20050101

Primary care use of antipsychotic drugs: an audit and intervention study.

Annals of general psychiatry 20050101

Comorbid anxiety and depression.

The Journal of clinical psychiatry 20050101

Treatment of agitation following traumatic brain injury: a review of the literature.

NeuroRehabilitation 20050101

Interactions between corticotropin-releasing hormone and serotonin: implications for the aetiology and treatment of anxiety disorders.

Handbook of experimental pharmacology 20050101

Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20050101

Convulsions in the treatment of obsessive-compulsive disorder.

Indian journal of psychiatry 20050101

Obsessive-compulsive disorder: An interface with possible psychotic features.

Indian journal of psychiatry 20050101

Buspirone to improve compliance in venlafaxine-induced movement disorder.

The international journal of neuropsychopharmacology 20041201

Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality.

Epilepsy & behavior : E&B 20041201

Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.

Progress in neuro-psychopharmacology & biological psychiatry 20041201

Generalised anxiety disorder.

Clinical evidence 20041201

Rapid high-performance liquid chromatographic measurement of buspirone in human plasma after overdose.

Biomedical chromatography : BMC 20041101

Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.

CNS spectrums 20041101

Interactions between anxiety, social support, health status and buspirone efficacy in elderly patients.

Progress in neuro-psychopharmacology & biological psychiatry 20041101

Anxiolytic-like effects of extracts from Albizzia julibrissin bark in the elevated plus-maze in rats.

Life sciences 20041022

Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort.

Stroke 20041001

Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.

Life sciences 20041001

Psychosocial conditions and the efficacy of clinically available anxiolytics.

Current drug targets 20041001

Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation.

The Journal of pharmacy and pharmacology 20041001

Effects of injection of serotonin into nucleus caudatus on food and water intake and body weight in albino rats.

Indian journal of physiology and pharmacology 20041001

Simple high-performance liquid chromatographic determination of buspirone in human plasma.

Farmaco (Societa chimica italiana : 1989) 20040901

Paroxetine in the treatment of generalised anxiety disorder.

Expert opinion on pharmacotherapy 20040801

Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling.

Neurology 20040727

Social instability in female rats: effects on anxiety and buspirone efficacy.

Psychopharmacology 20040701

The serotonin-1A agonist ipsapirone prevents ethanol-associated death of total rhombencephalic neurons and prevents the reduction of fetal serotonin neurons.

Brain research. Developmental brain research 20040621

Effect of the 5HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat.

European journal of pharmacology 20040621

Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide.

European journal of pharmacology 20040616

Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors.

Biochemical pharmacology 20040615

Buspirone raises blood pressure through activation of sympathetic nervous system and by direct activation of alpha1-adrenergic receptors after severe hemorrhage.

The Journal of pharmacology and experimental therapeutics 20040601

Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors.

Neuropharmacology 20040601

Buspirone challenge is not a valid probe of central 5-HT1A receptor function.

Cephalalgia : an international journal of headache 20040601

Prediction of the affinity of the newly synthesised azapirone derivatives for 5-HT1A receptors based on artificial neural network analysis of chromatographic retention data and calculation chemistry parameters.

Combinatorial chemistry & high throughput screening 20040601

Genotype-dependent changes in pain thresholds in adult mice after neonatal treatment.

Bulletin of experimental biology and medicine 20040601

Generalised anxiety disorder.

Clinical evidence 20040601

Cellular consequences of stress and depression.

Dialogues in clinical neuroscience 20040601

Effect of environmental enrichment on stress related systems in rats.

Journal of neuroendocrinology 20040501

[Combination of serotonergic agents resulted in severe adverse effects].

Lakartidningen 20040429

The design and preparation of metabolically protected new arylpiperazine 5-HT1A ligands.

Bioorganic & medicinal chemistry letters 20040405

Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.

Psychopharmacology 20040401

The photocatalytic process as a tool to identify metabolitic products formed from dopant substances: the case of buspirone.

Journal of pharmaceutical and biomedical analysis 20040401

Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations.

Journal of pharmaceutical and biomedical analysis 20040401

Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures.

Methods and findings in experimental and clinical pharmacology 20040401

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

International journal of clinical pharmacology and therapeutics 20040301

Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20040301

Current perspectives in the management of treatment-resistant depression.

Dialogues in clinical neuroscience 20040301

New imide 5-HT1A receptor ligands - modification of terminal fragment geometry.

Molecules (Basel, Switzerland) 20040227

Adsorptive stripping voltammetric behaviour of azomethine group in pyrimidine-containing drugs.

Journal of pharmaceutical and biomedical analysis 20040218

A rapid punishment procedure for detection of anxiolytic compounds in mice.

Psychopharmacology 20040201

Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour.

Neuropharmacology 20040201

The chick separation stress paradigm: a validation study.

Pharmacology, biochemistry, and behavior 20040201

Pharmacology of polymorphic variants of the human 5-HT1A receptor.

Biochemical pharmacology 20040201

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Controlled clinical trials 20040201

Myocardial perfusion scintigraphy: the evidence.

European journal of nuclear medicine and molecular imaging 20040201

Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983-1999).

Drug safety 20040101

Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats.

Journal of veterinary internal medicine 20040101

A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals.

The American journal on addictions 20040101

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Drugs 20040101

Effects of buspirone and alprazolam treatment on the startle-potentiated startle response.

Depression and anxiety 20040101

Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

CNS drugs 20040101

Pharmacotherapy of alcohol dependence: a review of the clinical data.

CNS drugs 20040101

Cortisol response to buspirone in extended abstinent alcoholics.

Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

Pharmacological treatments of cerebellar ataxia.

Cerebellum (London, England) 20040101

5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes.

Neuroimmunomodulation 20040101

Neonatal administration of buspiron causes changes in intermale aggression of adult mice.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20040101

1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat.

Neurourology and urodynamics 20040101

Selecting pharmacotherapy for generalized anxiety disorder.

The Journal of clinical psychiatry 20040101

Individual differences in the effects of serotonergic anxiolytic drugs on the motivation to self-administer cocaine.

Neuroscience 20040101

Induced depressive behavior impairs learning and memory in rats.

Neuroscience 20040101

Low-dose tiagabine effectiveness in anxiety disorders.

MedGenMed : Medscape general medicine 20040101

[Neurobiology and pharmacotherapy of social phobia].

L'Encephale 20040101

Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.

CNS drugs 20040101

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS drugs 20040101

[Effect of typical and atypical anxiolytics on the behavior and electrophysiological parameters of rats with model cerebrovascular pathology].

Eksperimental'naia i klinicheskaia farmakologiia 20040101

Physiology and clinical relevance of induced hypothermia.

Neurocritical care 20040101

Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze.

Behavioural brain research 20031217

Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.

European journal of clinical pharmacology 20031201

Sensitization of adenylate cyclase by short-term activation of 5-HT1A receptors.

Cellular signalling 20031201

The serotonergic system may be involved in the sleep-inducing action of oleamide in rats.

Naunyn-Schmiedeberg's archives of pharmacology 20031201

Sexual dysfunction with psychotropic drugs.

Expert opinion on pharmacotherapy 20031201

The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men.

Progress in neuro-psychopharmacology & biological psychiatry 20031201

Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice.

Journal of pharmacological sciences 20031201

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

British journal of cancer 20031117

Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat.

European journal of pharmacology 20031114

Ca2+ responses in Chinese hamster ovary-K1 cells demonstrate an atypical pattern of ligand-induced 5-HT1A receptor activation.

The Journal of pharmacology and experimental therapeutics 20031101

Buspirone for anxiety and agitation in dementia.

Journal of psychiatry & neuroscience : JPN 20031101

Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.

International journal of pharmaceutics 20031002

Harm avoidance, anxiety, and response to novelty in the adolescent S-100beta transgenic mouse: role of serotonin and relevance to Down syndrome.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031001

Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy.

Journal of clinical psychopharmacology 20031001

Buspirone treatment for apneustic breathing in brain stem infarct.

Respiratory care 20031001

Anxiety disorders in the child and teen.

Pediatric clinics of North America 20031001

Paroxetine: new indication. In generalised anxiety: uncertain efficacy.

Prescrire international 20031001

Effect of anxiolytic drugs on air-puff-elicited ultrasonic vocalization in adult rats.

Experimental animals 20031001

Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task.

European journal of pharmacology 20030923

Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.

Naunyn-Schmiedeberg's archives of pharmacology 20030901

Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.

Journal of affective disorders 20030901

The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?

Expert opinion on drug safety 20030901

Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice.

Biological psychiatry 20030901

Pharmacokinetic evaluation of gepirone immediate-release capsules and gepirone extended-release tablets in healthy volunteers.

Journal of pharmaceutical sciences 20030901

Stress, social avoidance and anxiolytics: a potential model of stress-induced anxiety.

Behavioural pharmacology 20030901

Effects of highly or relatively selective 5-HT1A receptor agonists on lordosis in female rats.

Zoological science 20030901

Chemical stimulants of leaf-trenching by cabbage loopers: natural products, neurotransmitters, insecticides, and drugs.

Journal of chemical ecology 20030901

The role of serotonergic agents as treatments for alcoholism.

Drugs of today (Barcelona, Spain : 1998) 20030901

Obsessive-compulsive spectrum disorders.

Dialogues in clinical neuroscience 20030901

Medication dependence and anxiety.

Dialogues in clinical neuroscience 20030901

Sleep and anxiety disorders.

Dialogues in clinical neuroscience 20030901

Modulation of 5-HT(1A) receptor-mediated Ca(2+) responses by co-expression with various recombinant G(alpha) proteins in CHO-K1 cells.

Naunyn-Schmiedeberg's archives of pharmacology 20030801

Methylphenidate-induced obsessive-compulsive symptoms in an elderly man.

CNS spectrums 20030801

An open trial of buspirone in the treatment of attention-deficit disorder.

Human psychopharmacology 20030801

A quantitative method for assessing of the affective component of the pain: conditioned response associated with CO2 laser-induced nocifensive reaction.

Brain research. Brain research protocols 20030801

WCA recommendations for the long-term treatment of generalized anxiety disorder.

CNS spectrums 20030801

The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone.

Life sciences 20030711

R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety.

Pharmacology, biochemistry, and behavior 20030701

Effects of autoshaping procedures on 3H-8-OH-DPAT-labeled 5-HT1a binding and 125I-LSD-labeled 5-HT2a binding in rat brain.

Brain research 20030613

A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats.

Psychopharmacology 20030601

Responses to exercise in the heat related to measures of hypothalamic serotonergic and dopaminergic function.

European journal of applied physiology 20030601

Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.

Neuropharmacology 20030601

Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models.

Stress (Amsterdam, Netherlands) 20030601

Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls.

Journal of affective disorders 20030601

Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.

AAPS pharmSci 20030601

Generalised anxiety disorder.

Clinical evidence 20030601

Serotonin 1A receptor agonists reverse respiratory abnormalities in spinal cord-injured rats.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030515

8-[3H]-hydroxy-2-(di-n-propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization.

Journal of neuroimmunology 20030501

Residual symptoms in depression: can treatment be symptom-specific?

The Journal of clinical psychiatry 20030501

[Circannual rhythm of drug use by a psychiatric clinic].

Psychiatrische Praxis 20030501

Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030501

22-kHz ultrasonic vocalization in rats as an index of anxiety but not fear: behavioral and pharmacological modulation of affective state.

Behavioural brain research 20030417

The anxiolytic CRF(1) antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats.

Psychopharmacology 20030401

GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030401

Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: interaction with serotonergic systems.

Neuropharmacology 20030401

Effects of ethanol and ipsapirone on the development of midline raphe glial cells and astrocytes.

Alcohol (Fayetteville, N.Y.) 20030401

Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents.

European journal of pharmacology 20030307

Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice.

Psychopharmacology 20030301

Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway.

Drug metabolism and disposition: the biological fate of chemicals 20030301

EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.

Psychopharmacology 20030301

Human cytochromes mediating gepirone biotransformation at low substrate concentrations.

Biopharmaceutics & drug disposition 20030301

Behavioral disturbances in dementia.

Dialogues in clinical neuroscience 20030301

Effects of antidepressants on the exploration, spontaneous motor activity and isolation-induced aggressiveness in mice.

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20030218

Effects of chronic treatment with ipsapirone and buspirone on the C57BL/6J strain mice under social stress.

Life sciences 20030214

Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets.

Journal of controlled release : official journal of the Controlled Release Society 20030214

Central 5-HT receptor hypersensitivity in migraine without aura.

Cephalalgia : an international journal of headache 20030201

5-HT1A receptor activity disrupts spontaneous alternation behavior in rats.

Pharmacology, biochemistry, and behavior 20030201

Venlafaxine-induced galactorrhea.

Journal of clinical psychopharmacology 20030201

Pseudo-Parkinson disease secondary to ritonavir-buspirone interaction.

The Annals of pharmacotherapy 20030201

Is there a role for 5-HT1A agonists in the treatment of depression?

Biological psychiatry 20030201

Effect of the serotonin agonist buspirone on behaviour and hypothalamic-pituitary-adrenal axis in confident and fearful mink.

Physiology & behavior 20030201

The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test.

Behavioural pharmacology 20030201

Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.

Pain 20030201

N-in-one permeability studies of heterogeneous sets of compounds across Caco-2 cell monolayers.

Pharmaceutical research 20030201

[Pharmacological treatment of post-traumatic behavioural disorders].

Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique 20030201

Development of a presynaptic 5-HT1A antagonist.

Bioorganic & medicinal chemistry letters 20030120

In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity.

European journal of pharmacology 20030110

Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli.

Psychopharmacology 20030101

Effects of cholecystokinin tetrapeptide (CCK(4)) and of anxiolytic drugs on GABA outflow from the cerebral cortex of freely moving rats.

Neurochemistry international 20030101

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

American journal of physiology. Gastrointestinal and liver physiology 20030101

Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.

The Journal of pharmacology and experimental therapeutics 20030101

Treating generalized anxiety disorder.

The Journal of clinical psychiatry 20030101

Alcohol and psychiatric comorbidity.

Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 20030101

Update on the role of drug therapy in non-ulcer dyspepsia.

Reviews in gastroenterological disorders 20030101

Anxiolytic effect of ting-chih-wan in mouse behavior models of anxiety.

The American journal of Chinese medicine 20030101

Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.

Phytomedicine : international journal of phytotherapy and phytopharmacology 20030101

Effects of buspirone in withdrawal from opiates.

The American journal on addictions 20030101

Effects of acute tryptophan depletion on executive function in healthy male volunteers.

BMC psychiatry 20030101

Mirtazapine in L-dopa-induced dyskinesias.

Clinical neuropharmacology 20030101

Pharmacotherapy of social phobia.

Acta psychiatrica Scandinavica. Supplementum 20030101

Electrospray mass spectrometric studies of noncovalent complexes of buspirone hydrochloride and other serotonin 5-HT(1A) receptor ligands containing arylpiperazine moieties.

Rapid communications in mass spectrometry : RCM 20030101

[Effect of buspirone on aggressive and anxiety behavior of male mice with various aggressive experience].

Eksperimental'naia i klinicheskaia farmakologiia 20030101

What is a significant response in drug studies of attention-deficit/hyperactivity disorder: statistical significance is necessary, but is it sufficient?

Psychopharmacology bulletin 20030101

Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment.

Psychosomatic medicine 20030101

Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.

American journal of respiratory medicine : drugs, devices, and other interventions 20030101

Buspirone in Alzheimer's disease.

Expert review of neurotherapeutics 20030101

Effects of ethanol and 5-HT1A agonists on astroglial S100B.

Brain research. Developmental brain research 20021215

Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction.

Journal of the American College of Cardiology 20021204

The treatment of generalised anxiety disorder. A systematic review.

Panminerva medica 20021201

Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.

The Journal of pharmacology and experimental therapeutics 20021201

Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo.

Journal of affective disorders 20021201

Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.

Psychopharmacology 20021201

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

British journal of clinical pharmacology 20021201

Possible serotonin syndrome after combination of buspirone and St John's Wort.

Journal of psychopharmacology (Oxford, England) 20021201

Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies.

Bipolar disorders 20021201

Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain.

Neuropharmacology 20021201

Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine.

Behavioural pharmacology 20021101

Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits.

British journal of pharmacology 20021101

Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists.

Farmaco (Societa chimica italiana : 1989) 20021101

Effects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys.

Experimental and clinical psychopharmacology 20021101

5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.

European journal of pharmacology 20021025

What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder.

American family physician 20021015

5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain.

European journal of pharmacology 20021004

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20021001

Involvement of 5-HT1A and 5-HT2 receptor in cisplatin induced emesis in dogs.

Indian journal of physiology and pharmacology 20021001

Developing strategies for isolation of minor impurities with mass spectrometry-directed fractionation.

Journal of chromatography. A 20020913

Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone.

Pharmacology, biochemistry, and behavior 20020901

The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020901

The effects of alprazolam and buspirone in light and moderate female social drinkers.

Behavioural pharmacology 20020901

Psychopharmacology of anxiety disorders.

Dialogues in clinical neuroscience 20020901

Nonpharmacological treatments for anxiety disorders.

Dialogues in clinical neuroscience 20020901

Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020801

Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method.

Drug metabolism and disposition: the biological fate of chemicals 20020801

A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity?

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801

Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol.

The Journal of pharmacology and experimental therapeutics 20020801

Clinical inquiries. What are the treatment options for SSRI-related sexual dysfunction?

The Journal of family practice 20020801

Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.

Psychopharmacology 20020801

[Buspirone chlorhydrate in the treatment of cerebellar ataxia].

Revista de neurologia 20020801

[Preparation of buspirone hydrochloride buccal adhesive tablet and study on its drug release mechanism].

Yao xue xue bao = Acta pharmaceutica Sinica 20020801

Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.

Psychopharmacology 20020701

The use of buspirone in primary care.

Journal of psychosocial nursing and mental health services 20020701

Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect?

Behavioural pharmacology 20020701

Efficacy of newer antidepressants for childhood anxiety disorders.

Expert review of neurotherapeutics 20020701

[Serotonin syndrome--several cases of this often overlooked diagnosis].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20020630

Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo.

Neuroscience letters 20020628

Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury.

Psychopharmacology 20020601

Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain.

The international journal of neuropsychopharmacology 20020601

Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

Dialogues in clinical neuroscience 20020601

Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.

European journal of pharmacology 20020517

Extended action of MKC-242, a selective 5-HT(1A) receptor agonist, on light-induced Per gene expression in the suprachiasmatic nucleus in mice.

Journal of neuroscience research 20020515

Rifampin and rifabutin drug interactions: an update.

Archives of internal medicine 20020513

[Serotonin syndrome. Several cases of this often overlooked diagnosis].

Lakartidningen 20020502

The pharmacological treatment of anxiety disorders in children and adolescents.

Expert opinion on pharmacotherapy 20020501

Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

The Journal of biological chemistry 20020419

Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.

Neurochemistry international 20020401

Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury.

Brain injury 20020401

Contact leukoderma caused by buspirone patches.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 20020301

[Buspirone increases D2-like dopaminergic receptor density in rat corpus striatum].

Arquivos de neuro-psiquiatria 20020301

The role of substance P in depression: therapeutic implications.

Dialogues in clinical neuroscience 20020301

Benzodiazepine discontinuation in generalized anxiety disorder.

The American journal of psychiatry 20020201

Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020201

Bupropion-induced acute dystonia.

The Annals of pharmacotherapy 20020201

Olfactory-mediated fear-potentiated startle.

Behavioral neuroscience 20020201

Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608).

European journal of pharmacology 20020125

Short term aerobic exercise training in young males does not alter sensitivity to a central serotonin agonist.

Experimental physiology 20020101

The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine.

Pharmacology, biochemistry, and behavior 20020101

Anxiogenic activity of Myristica fragrans seeds.

Pharmacology, biochemistry, and behavior 20020101

Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer.

Die Pharmazie 20020101

Atypical kinetics for a series of putative dopamine antagonists to reverse the low-magnitude Ca2+ phase in the dopamine-bound D2short receptor state.

Naunyn-Schmiedeberg's archives of pharmacology 20020101

Light-enhanced startle: further pharmacological and behavioral characterization.

Psychopharmacology 20020101

Seed finding in golden hamsters: a potential animal model for screening anxiolytic drugs.

Neuropsychobiology 20020101

Factors explaining variance in perceived pain in women with fibromyalgia.

BMC musculoskeletal disorders 20020101

Treatment of generalized anxiety disorder.

The Journal of clinical psychiatry 20020101

Drug treatments for obstructive sleep apnoea.

The Cochrane database of systematic reviews 20020101

Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.

Molecular psychiatry 20020101

[Review of psychopharmacological treatments in adolescents and adults with autistic disorders].

L'Encephale 20020101

Generalised anxiety disorder: treatment options.

Drugs 20020101

Pharmacology of flibanserin.

CNS drug reviews 20020101

Glucose intolerance with atypical antipsychotics.

Drug safety 20020101

Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.

Journal of receptor and signal transduction research 20020101

Repeated treatment with selective serotonin reuptake inhibitors but not anxiolytics prevents the stress-induced deficit of fighting behavior.

Polish journal of pharmacology 20020101

Pharmacotherapy of generalized anxiety disorder.

The Journal of clinical psychiatry 20020101

13C cpmas nmr and molecular modeling in the studies of new analogues of buspirone.

Acta poloniae pharmaceutica 20020101

Effects of cholecystokinin tetrapeptide (CCK(4)) and anxiolytic drugs on the electrically evoked [(3)H]5-hydroxytryptamine outflow from rat cortical slices.

Brain research 20011213

trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.

Journal of medicinal chemistry 20011206

Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults.

Journal of clinical pharmacology 20011201

Effect of nonnicotine pharmacotherapy on smoking behavior.

Pharmacotherapy 20011201

The impact of impulsivity on cocaine use and retention in treatment.

Journal of substance abuse treatment 20011201

Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze.

Neuroscience and biobehavioral reviews 20011201

Astrocyte-mediated trophic support of developing serotonin neurons: effects of ethanol, buspirone, and S100B.

Brain research. Developmental brain research 20011126

Buspirone and meperidine synergistically reduce the shivering threshold.

Anesthesia and analgesia 20011101

Quantifying the 5-HT1A agonist action of buspirone in man.

Psychopharmacology 20011101

Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia.

Behavioural pharmacology 20011101

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

The Journal of clinical psychiatry 20011101

Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.

Journal of computer-aided molecular design 20011101

Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study.

Psychoneuroendocrinology 20011001

Small platform stress increases exploratory activity of mice in staircase test.

Progress in neuro-psychopharmacology & biological psychiatry 20011001

A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?

Alimentary pharmacology & therapeutics 20011001

The effect of glucocorticoids on the anxiolytic efficacy of buspirone.

Psychopharmacology 20011001

Venlafaxine and generalised anxiety disorder: new preparation. Minimise recourse to drugs.

Prescrire international 20011001

Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats.

Pharmacology, biochemistry, and behavior 20010901

Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.

The Journal of clinical psychiatry 20010901

An open study of buspirone augmentation of neuroleptics in patients with schizophrenia.

Journal of clinical psychopharmacology 20010801

Ataxia from lithium toxicity successfully treated with high-dose buspirone: a single-case experimental design.

Archives of physical medicine and rehabilitation 20010801

A comparative multidose pharmacokinetic study of buspirone extended-release tablets with a reference immediate-release product.

Journal of clinical pharmacology 20010801

Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010801

Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.

The Journal of clinical psychiatry 20010801

Gepirone. Organon.

Current opinion in investigational drugs (London, England : 2000) 20010801

[Permeation of buspirone hydrochloride across animal buccal mucosa and its mechanism].

Yao xue xue bao = Acta pharmaceutica Sinica 20010801

Characterization of alpha1-adrenoceptor-mediated contraction in the mouse thoracic aorta.

European journal of pharmacology 20010720

Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem.

The British journal of psychiatry : the journal of mental science 20010701

Late-onset bipolar disorder due to hyperthyroidism.

Acta psychiatrica Scandinavica 20010701

Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression.

Molecular psychiatry 20010701

Pharmacokinetics of buspirone extended-release tablets: a single-dose study.

Journal of clinical pharmacology 20010701

An open trial of divalproex sodium in autism spectrum disorders.

The Journal of clinical psychiatry 20010701

Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

Psychopharmacology 20010701

Potential involvement of S100B in the protective effects of a serotonin-1a agonist on ethanol-treated astrocytes.

Brain research. Developmental brain research 20010629

SSRI discontinuation and buspirone.

The American journal of psychiatry 20010601

Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.

The Journal of clinical psychiatry 20010601

An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice.

Behavioural pharmacology 20010601

5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.

European journal of pharmacology 20010525

Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.

Pharmacology 20010501

Quantifying drug-related 5-HT1A receptor occupancy with.

Psychopharmacology 20010501

Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.

Psychopharmacology 20010501

Does pretreatment anxiety predict response to either bupropion SR or sertraline?

Journal of affective disorders 20010401

Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors.

Bioorganic & medicinal chemistry 20010401

Synthesis and pharmacological evaluation of aryl/heteroaryl piperazinyl alkyl benzotriazoles as ligands for some serotonin and dopamine receptor subtypes.

Farmaco (Societa chimica italiana : 1989) 20010401

Effect of anxiolytics on blood sugar level in rabbits.

Indian journal of experimental biology 20010401

Ligand induced conformational states of the 5-HT(1A) receptor.

European journal of pharmacology 20010323

Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT(1A) receptor agonist, using a behavioural model in rats.

European journal of pharmacology 20010302

S 14506: novel receptor coupling at 5-HT(1A) receptors.

Neuropharmacology 20010301

Pharmacologic treatment of generalized anxiety disorder.

The Psychiatric clinics of North America 20010301

Generalized anxiety disorder in children and adolescents.

The Psychiatric clinics of North America 20010301

Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use?

The Journal of family practice 20010301

Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.

Journal of psychopharmacology (Oxford, England) 20010301

Discriminative stimulus properties of indorenate in a conditioned taste aversion paradigm.

Pharmacology, biochemistry, and behavior 20010301

New 5-HT1A receptor agonists possessing 1,4-benzoxazepine scaffold exhibit highly potent anti-ischemic effects.

Bioorganic & medicinal chemistry letters 20010226

Female sexual dysfunction and antidepressant use.

The American journal of psychiatry 20010201

Citalopram-induced bruxism.

The British journal of psychiatry : the journal of mental science 20010201

Acute hypokalemic paralysis associated with long-term lithium therapy.

Muscle & nerve 20010201

Prenatal stress and postnatal development of neonatal rats--sex-dependent effects on emotional behavior and learning ability of neonatal rats.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20010201

Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice.

Psychopharmacology 20010201

Extracellular serotonin is enhanced in the striatum, but not in the dorsal hippocampus or prefrontal cortex, in rats subjected to an operant conflict procedure.

Behavioral neuroscience 20010201

Behavioral effects of buspirone in the marmoset employing a predator confrontation test of fear and anxiety.

Pharmacology, biochemistry, and behavior 20010201

Anxiety-like behavior in elevated plus-maze tests in repeatedly cold-stressed mice.

Japanese journal of pharmacology 20010201

Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20010101

Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.

British journal of pharmacology 20010101

Serotonin syndrome. A common but often unrecognized psychiatric condition.

Geriatrics 20010101

Recovery from chronic fatigue syndrome associated with changes in neuroendocrine function.

Journal of the Royal Society of Medicine 20010101

Strategies for the treatment of antidepressant-related sexual dysfunction.

The Journal of clinical psychiatry 20010101

New developments in the pharmacotherapy of alcohol dependence.

The American journal on addictions 20010101

Use of negatively reinforcing electrical brain stimulation to detect conventional and nonconventional anxiolytics as well as an anxiogenic drug.

Pharmacology, biochemistry, and behavior 20010101

Pharmacotherapy of generalized anxiety disorder.

The Journal of clinical psychiatry 20010101

Neuropharmacological analysis of the role of the serotoninergic system in forming hyperalgesia in neurotic rats.

Neuroscience and behavioral physiology 20010101

Contemporary management of comorbid anxiety and depression in geriatric patients.

The Journal of clinical psychiatry 20010101

Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management.

CNS drugs 20010101

Conformational analysis and pharmacophore design for selected 1-(2-pyrimidinyl)piperazine derivatives with sedative-hypnotic activity.

Acta poloniae pharmaceutica 20010101

Behavioral and biochemical effects of L-tryptophan and buspirone in a model of cerebellar atrophy.

Pharmacology, biochemistry, and behavior 20010101

Treatment of the agitation of late-life psychosis and Alzheimer's disease.

European psychiatry : the journal of the Association of European Psychiatrists 20010101

Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder.

The Journal of clinical psychiatry 20010101

Effect of citalopram and buspirone on the antinociceptive action of analgesic drugs.

Acta poloniae pharmaceutica 20010101

Controversies in dyspepsia.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 20010101

[The role of neuropeptide Y in anxiety].

Psychiatria polska 20010101

Estimation of buspirone-bovine serum albumin binding by affinity capillary electrophoresis.

Acta poloniae pharmaceutica 20010101

[New drugs for the treatment of functional dyspepsia].

Arquivos de gastroenterologia 20010101

Sertraline and buspirone in adolescent delusional body dysmorphic disorder.

Indian journal of psychiatry 20010101

5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20001201

Involvement of 5-hydroxytryptamine(1A) receptors in nicotine-induced tail tremor in rats.

European journal of pharmacology 20001110

Effects of serotoninergic drugs on tremor induced by physostigmine in rats.

Behavioural brain research 20000501

Cerebellar Ataxia.

Current treatment options in neurology 20000501

Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors.

The Journal of pharmacology and experimental therapeutics 20000201

Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention.

The American journal of psychiatry 20000201

Possible serotonin syndrome associated with buspirone added to fluoxetine.

The Annals of pharmacotherapy 20000101

Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.

Journal of clinical psychopharmacology 19990601

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.

European journal of pharmacology 19980821

Apomorphine-induced aggressiveness and [3H]citalopram binding after antidepressant treatment in rats.

Pharmacology, biochemistry, and behavior 19980301

Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.

Naunyn-Schmiedeberg's archives of pharmacology 19980301

Seizures associated with buspirone overdose: case report and literature review.

Clinical neuropharmacology 19980101

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.

European journal of pharmacology 19970501

Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.

International clinical psychopharmacology 19970101

[Regulation of the central opioidergic nervous system on the emotional state of anxiety and its possible mechanisms].

Sheng li ke xue jin zhan [Progress in physiology] 19970101

The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study.

Journal of intellectual disability research : JIDR 19961201

Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.

The Journal of clinical psychiatry 19960701

Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.

The Journal of pharmacology and experimental therapeutics 19960701

Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission.

Critical care medicine 19960601

Baclofen-induced catatonia: modification by serotonergic agents.

Neuropharmacology 19960501

Disappearance of psychosis after buspirone treatment.

The American journal of psychiatry 19960201

[Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].

L'Encephale 19960101

Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.

Clinical pharmacology and therapeutics 19950301

Buspirone in levodopa-induced dyskinesias.

Clinical neuropharmacology 19940201

Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.

Proceedings of the National Academy of Sciences of the United States of America 19930915

Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.

Molecular pharmacology 19930801

Persistent movement disorders induced by buspirone.

Movement disorders : official journal of the Movement Disorder Society 19930701

Serotonergic involvement in haloperidol-induced catalepsy.

The Journal of pharmacology and experimental therapeutics 19930401

High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells.

The Biochemical journal 19920801

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.

Journal of clinical psychopharmacology 19920201

Seizure associated with fluoxetine and adjuvant buspirone therapy.

Journal of clinical psychopharmacology 19920201

Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.

Journal of psychiatry & neuroscience : JPN 19911101

Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal.

Psychopharmacology 19910101

Buspirone-induced mania.

The British journal of psychiatry : the journal of mental science 19910101

Persistent dystonia associated with buspirone.

Neurology 19901201

Paradoxical reaction to buspirone augmentation of fluoxetine.

Journal of clinical psychopharmacology 19901001

Evidence that central 5-HT1A-receptors play a role in the von Bezold-Jarisch reflex in the rat.

British journal of pharmacology 19900801

[Acute toxicity study of buspirone hydrochloride in mice, rats and dogs].

The Journal of toxicological sciences 19900401

The effect of serotonergic agents on haloperidol-induced catalepsy.

Life sciences 19900101

Possible induction of mania by buspirone.

The American journal of psychiatry 19900101

Panic and hypertension associated with single dose of buspirone.

Lancet (London, England) 19890701

Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.

The American journal of psychiatry 19890701

Buspirone-induced mania.

Journal of clinical psychopharmacology 19890401

Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction.

Psychopharmacology 19890101

Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs.

The Journal of pharmacy and pharmacology 19881201

Strychnine seizure potentiation by azaspirodecanedione anxiolytics in rats.

European journal of pharmacology 19881018

Acute generalized myoclonus following buspirone administration.

The Journal of clinical psychiatry 19880601

Buspirone-induced hypomania: a case report.

Journal of clinical psychopharmacology 19880601

Combined effects of buspirone and diazepam on objective and subjective tests of performance in healthy volunteers.

Clinical pharmacology and therapeutics 19861201

Review of the side-effect profile of buspirone.